Pharmaceuticals
US government clears AstraZeneca’s Brilinta over concerns related to trial process
20 August 2014
Sun Pharma unit recalls Cephalexin capsules in US market
16 August 2014
Doctor-pharma nexus to prescribe needless, costly drugs exposed
13 August 2014
Canada to donate Ebola vaccine to fight outbreak in West Africa
13 August 2014
Pfizer hit with lawsuits over Lipitor
11 August 2014
GSK China's private investigators sentenced for theft, trading private information
09 August 2014
Pharma industry not happy with new drug price controls
09 August 2014
Sanofi Emcure in pact to market oncology drugs
06 August 2014
US-dependant Indian pharma firms must pay 12-15% more in FDA fees
04 August 2014
Drug resistance to malaria increasing warn experts
31 July 2014
Cadila Healthcare says it is ‘responding' to FDA strictures
31 July 2014
Transparency lacking in clinical trials: study
31 July 2014
AstraZeneca to acquire rights to Almirall’s lung drugs
30 July 2014
Ranbaxy reports Rs190-cr quarterly loss after settlement with US FDA
30 July 2014
Reckitt Benckiser to spin off pharma business
28 July 2014
AstraZeneca, Roche, Qiagen in collaboration on lung cancer tests
28 July 2014
GlaxoSmithKline to launch first-ever malaria vaccine
26 July 2014
US jury indicts Indian-origin doc for peddling prescription drugs
25 July 2014
Australian biotech firm set to market HIV-killing condoms
24 July 2014
Sebi clears Zuari Fertilisers-UB Group joint bid for Mangalore Chemicals
22 July 2014
Strides Arcolabs to acquire Bafna Pharma's entire branded generics portfolio
21 July 2014
UK’s Bestway buys Co-operative’s pharmacy chain for £620 mn
21 July 2014
Shire's board agrees to £32-bn takeover by AbbVie
18 July 2014
AstraZeneca plans £330m R&D centre and corporate HQ in Cambridge
18 July 2014
Three Indian companies to benefit from UN arm’s generics pact
17 July 2014
After Ranbaxy acquisition, Sun Pharma set to own Pharmalucence of US
16 July 2014
India brings diabetes, heart-disease drugs under price control
14 July 2014
Sanofi announces results of first Phase III dengue vaccine in The Lancet
14 July 2014
China indicts two foreign investigators in Glaxo bribery scam
14 July 2014
UK drug firm Shire approves AbbVie's £30-bn takeover offer
14 July 2014
UK drug maker Shire confirms merger talks with AbbVie
12 July 2014
UK animal activists furious over rise in lab testing despite govt promise
11 July 2014
Genentech to pay up to $1.7 bn for oncology firm Seragon
03 July 2014
Cipla to acquire 51% stake in Yemeni pharma firm
30 June 2014
Ranbaxy’s US arm gets FDA nod to market generic Diovan
27 June 2014
India may extend price control to more drugs
25 June 2014
AstraZeneca India delisting under Sebi lens for cheating investors
25 June 2014
Dr Reddy’s Lab recalls 13,560 bottles of heart drug in US
21 June 2014
Collectis shares surge on Pfizer deal
19 June 2014
Valeant starts hostile takeover process for Allergan
19 June 2014
Cipla buys 60% stake in Sri Lankan co in marketing push
17 June 2014
Japan’s Mieji Holdings buys out Medreich for $290 mn
12 June 2014
DIPP seeks curbs as UPA-II clears over 49% FII stake in pharma sector
09 June 2014
EU lifts ban on Ranbaxy’s Toansa-made drugs
06 June 2014
Medtronic mulls takeover of London-based Smith & Nephew
05 June 2014
US FDA gives `fast-track’ status for AstraZeneca’s novel antibiotic for treatment of gonorrhea
04 June 2014
FDA hits Wockhardt again; this time over Illinois plant
04 June 2014
Valeant raises offer for the second time this week for Allergan to $53.8 bn
31 May 2014
Zydus Group initiates Phase III trials of Lipalglyn drug for use in lipodystrophy
30 May 2014
Stryker denies Smith & Nephew bid
29 May 2014
Valeant raises Allergan bid to $49.44 bn: analysts say new offer still too low
29 May 2014
Nestlé to buy five skin care products from Valeant for $1.4 bn
28 May 2014
British watchdog launches criminal probe into GSK over bribery
28 May 2014
Pfizer drops AstarZeneca take over bid
28 May 2014
AP High Court vacates stay on Ranbaxy-Sun Pharma merger
24 May 2014
US FDA warns Sun Pharma over manufacturing practices at Karkhadi plant
22 May 2014
FDA continues import ban on Sun Pharma drugs despite pleas
21 May 2014
SC blasts manner of stalling Sun-Ranbaxy merger
21 May 2014
Walgreen prepares to buy British pharmacy retailer Alliance Boots in a $17.6 bn deal
20 May 2014
AstraZeneca rejects Pfizer’s third takeover offer
19 May 2014
Pfizer raises bid for AstraZeneca to $118.8 bn, says latest offer is final
19 May 2014
FDA forces Wockhardt to withdraw yet another generic drug from US
17 May 2014
Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal
17 May 2014
AstraZeneca plans research alliance with MRC Laboratory of Molecular Biology
16 May 2014
Bayer to sell interventional device business to Boston Scientific
16 May 2014
Sun Pharma settles litigation over Novaris’s cancer drug Gleevec
15 May 2014
GSK’s former China head charged with bribery
14 May 2014
Dr Reddy’s management rejig remains largely en famille
14 May 2014
Merck & Co to sell some eye care products to Japan’s Santen Pharmaceutical for $600 mn
13 May 2014
AstraZeneca snubs Pfizer’s “opportunistic” bid
13 May 2014
Botox maker Allergan rejects Valeant's $45.7-b hostile bid
12 May 2014
Irish drugmaker Shire to buy Lumena Pharma to shore up rare diseases portfolio
12 May 2014
Cipla buys 14.6% stake in Chase Pharma to support Alzheimer treatment
12 May 2014
Cinven may sell French medical diagnostics company Sebia for €1 bn
12 May 2014
US, British lawmakers wary of Pfizer’s bid to buy AstraZeneca
10 May 2014
Danish drugmaker Lundbeck to buy Chelsea Therapeutics for $658 mn
09 May 2014
Pfizer seeks to allay fears over AstraZeneca deal
07 May 2014
Merck & Co to sell consumer care business to Germany's Bayer for $14.2 bn
06 May 2014
Pfizer considering "all strategies" in AstraZeneca bid
06 May 2014
Sterigenics raises bid for Canadian isotope supplier Nordion to $758 mn
06 May 2014
Cable admits Pfizer-AstaraZeneca deal involves ‘national interest’ issues
05 May 2014
Abbott Laboratories seeks to sell mature drugs worth more than $5 bn: report
05 May 2014
Sun Pharma closes Detroit facility to consolidate US operations
03 May 2014
AstraZeneca rejects Pfizer’s revised $106 billion offer
02 May 2014
AstraZeneca to consider Pfizer’s $106-bn bid
02 May 2014
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 April 2014
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 April 2014
Allergan set to approach Shire Plc once again: report
29 April 2014
Reckitt Benckiser confirms bidding for Merck & Co's consumer health business
29 April 2014
Pfizer confirms AstraZeneca's rejection; to explore options
28 April 2014
Forest Labs to buy GI specialist Furiex in $1.46-bn deal
28 April 2014
Prestige Brands to buy Insight Pharmaceuticals for $750 mn
26 April 2014
Mylan tables sweetened bid for Swedish generic drugmaker Meda
26 April 2014
India’s pharma export growth hits a 15-year low as US holds on to import curbs
25 April 2014
Greater investment needed to check malaria: WHO
25 April 2014
Britain’s Shire Plc recently rejected Allergan’s takeover approach: report
25 April 2014
US medical device maker Zimmer to buy Biomet for $13.35 bn
24 April 2014
AstraZeneca’s Q1-14 revenue marginally up at$6.42 bn, profit falls
24 April 2014
Lupin in pact with Japan’s Yoshindo to set up joint venture `YL Biologics’
23 April 2014
Valeant tables hostile $45.7 bn bid for Botox maker Allergan
23 April 2014
Novartis AG, GSK in $23-bn assets swap deal
22 April 2014
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 April 2014
Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn
22 April 2014
Pfizer weighs $101-bn bid for AstraZeneca
21 April 2014
US Supreme Court turns down Teva's bid to block Mylan's generic Copaxone
19 April 2014
Glenmark recalls anti-ulcer drug in the US over tablet mix-up
19 April 2014
GSK's statement on media reports on misconduct of employees
17 April 2014
After China, Iraq, Poland, GSK bribery probe now expands to Jordan, Lebanon
17 April 2014
Dr Reddy’s announces the Launch of Eszopiclone tablets C-IV
16 April 2014
US surgical device maker ConMed explores sale under investor pressure
16 April 2014
Lupin recalls Suprax drug from US market after failing to meet US purity test
15 April 2014
US taxes put pressure on drug chain Walgreen to migrate to Europe
15 April 2014
Akorn's $640-mn merger with Hi-Tech Pharmacal gets conditional approval
15 April 2014
After China and Iraq, GSK now faces bribery probe in Poland
14 April 2014
Sun Pharma to make mandatory open offer to buy 28.1% of Zenotech
12 April 2014
Natco Pharma opposes Indian patent for Gilead’s hepatitis drug
11 April 2014
Suven Life secures new patents in Canada, Hong Kong
10 April 2014
Ranbaxy drug flows to Europe, US to dry up
09 April 2014
GSK launches probe into unethical conduct in Iraq
09 April 2014
Takeda fined record $6 bn over diabetes drug Actos; Eli Lilly $3 bn
08 April 2014
Irish drugmaker Mallinckrodt to buy Questcor Pharmaceuticals for $5.6 bn
08 April 2014
Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal
07 April 2014
Swedish drug maker Meda rejects takeover offer from Mylan
05 April 2014
Pollution board withholds approvals to new units in Vizag pharma city
05 April 2014
Health ministry seeks compulsory licence for Bristol-Myers' cancer drug
03 April 2014
AstraZeneca in strategic R&D collaboration with UK Medical Research Council
01 April 2014
J&J accepts $4 bn bid from Carlyle for its ortho-clinical diagnostics business
01 April 2014
US sterilisation services provider Sterigenics to buy Canada’s Nordion for $727 mn
01 April 2014
Senior AIIMS doc complains of poor quality drugs at hospital
29 March 2014
Baxter International to spin off biopharma business in 2015
28 March 2014
Delhi HC bars export of Natco's generic cancer drug on Bayer’s plea
27 March 2014
Lupin to buy Mexican eye-treatments maker Laboratorios Grin
27 March 2014
AstraZeneca completes buy-out of Sumitomo Chemical’s stake in AstraZeneca KK
26 March 2014
India ready to defend its IPR norms at WTO: Sharma
24 March 2014
Horizon Pharma to buy Ireland’s Vidara Therapeutics for $660 mn
19 March 2014
AstraZeneca confirms de-listing from Indian bourses
19 March 2014
SC notices to Ranbaxy, govt over selling ‘adulterated’ drugs
15 March 2014
Competition panel slaps Rs18-cr penalty on Bengal druggists body
14 March 2014
And now, USFDA bans imports from Sun Pharma unit
13 March 2014
GSK spends $1.05 bn to raise stake in Indian arm
11 March 2014
Indian generic drugs ideal for Africa, suggests Anand Sharma
10 March 2014
Shasun Pharmaceuticals signs joint venture agreement with Sequent
08 March 2014
US orphan-drug maker InterMune evokes takeover interest
08 March 2014
Shocking dosage mix-up forces Ranbaxy to recall generic Liptor in US
08 March 2014
Italian regulator fines Novartis, Roche $250 mn over collusion in eye treatment drugs
06 March 2014
May collaborate, not take over Roche: Novartis
03 March 2014
Bayer to buy Chinese traditional herbal medicine maker Dihon Pharmaceutical
28 February 2014
Indian generics still unsafe despite FDA efforts, US lawmakers told
27 February 2014
Ranbaxy suspends all shipments from Toansa, Dewas plants
25 February 2014
Eli Lilly’s Elanco to buy Germany’s Lohmann Animal Health
25 February 2014
Drug CRO Medpace to be sold to European PE firm Cinven for $915 mn
25 February 2014
Bayer close to bagging cancer drug maker Algeta for $2.9-bn
24 February 2014
PE firm Cinven close to buying contract research firm Medpace for $900 mn
24 February 2014
Endo Health fined $192.7 mn over improper marketing of shingles drug Lidoderm
24 February 2014
Not targeting India, but US standards must be met: FDA’s Hamburg
22 February 2014
Drug trials in India cost over 59 lives in four years: government report
22 February 2014
Roche to share Avastin data from trial to determine benefits to glioblastoma patients
21 February 2014
Ranbaxy, Teva to pay $15,000 each to settle US anti-trust case
20 February 2014
Bayer, Novartis, Reckitt Benckiser, P&G in fray for Merck & Co's consumer healthcare unit
20 February 2014
Actavis to acquire Forest Laboratories for $25 billion
19 February 2014
India, US must work jointly for lifting FDA ban: Hamburg
19 February 2014
FDA pushes for warnings on generic drugs
18 February 2014
Actavis in talks to buy Forest Laboratories for around $25 bn
18 February 2014
Novartis acquires biotechnology company CoStim Pharmaceuticals
17 February 2014
Appeals by Indian drug firms fail to impress FDA’s Hamburg
17 February 2014
Flawed law denies European kids life-saving cancer drugs: experts
12 February 2014
Mallinckrodt to acquire biopharmaceutical firm Cadence Pharmaceuticals for $1.3 bn
11 February 2014
US, Indian drug authorities agree on regulatory cooperation
11 February 2014
Cheaper drugs not necessarily spurious, India tells US FDA
11 February 2014
Merck & Co agrees to pay $100 mn to settle NuvaRing contraceptive lawsuits
08 February 2014
Pharma MNCs seek US action against generic threat from India
06 February 2014
FDA ban will only impact US business 10-15%: Ranbaxy
06 February 2014
Azad gives pharma firms hopes of easing clinical trial norms
06 February 2014
Biotech firm Biocon ties up with Baxter for new research centre
06 February 2014
Myriad Genetics to buy Crescendo Bioscience
05 February 2014
Lupin acquires Dutch injectable company Nanomi BV
04 February 2014
Valeant Pharmaceuticals to buy PreCision Dermatology for $475 mn
04 February 2014
CCI warns pharma trade against anti-competitive practices
03 February 2014
Rexam to sell two healthcare units to Montagu Private Equity for $805 mn
03 February 2014
Smith & Nephew to buy medical devices firm ArthroCare for $1.7 bn
03 February 2014
Merck & Co mulls sale of consumer healthcare, animal health businessess
01 February 2014
After FDA, Ranbaxy under scanner of Indian authorities too
30 January 2014
GVK Bio to acquire US-based CRO Aragen Bioscience
29 January 2014
Ranbaxy hit afresh by FDA; all its India-made products banned
24 January 2014
McKesson Corp secures acquisition of German drugs distributor Celesio in new deal
24 January 2014
Quest Diagnostics to buy Solstas Lab for $570 mn
23 January 2014
Biocon to launch breast cancer drug 'CANMAb' next month
18 January 2014
Aurobindo Pharma to acquire Actavis’s European operations
18 January 2014
Shire to sell diabetic foot ulcer treatment Dermagraft to Organogenesis Inc
17 January 2014
J&J to sell Ortho Clinical Diagnostics unit to Carlyle for $4.15 bn
17 January 2014
US FDA raises concerns over a fourth Ranbaxy facility
14 January 2014
Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics
13 January 2014
Novartis arm faces criminal case in Japan over exaggerated advertising
09 January 2014
Forest Labs acquires Aptalis for $2.9 bn
09 January 2014
Government sticks to 100% FDI in pharma takeovers
08 January 2014
Thermo Fischer to sell cell research business to GE for over $1 bn
07 January 2014
Drug companies in UK not sharing complete information on clinical trials with doctors: MPs
04 January 2014
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 December 2013
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 December 2013
Blackstone signs agreement to sell stake in Emcure Pharmaceuticals to Bain Capital
20 December 2013
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 December 2013
Bayer to acquire cancer drug maker Algeta
19 December 2013
Wockhardt’s Swiss arm to list on Berne exchange today; shares spurt
19 December 2013
S Africa’s Public Investment Corp stalls Chilean bid for drugmaker Adcock
18 December 2013
GlaxoSmithKline to stop paying doctors for product promotion
17 December 2013
Canada’s Valeant Pharma to acquire US-based Solta Medical for $250 mn
17 December 2013
Glaxo announces open offer to hike stake in Indian arm
16 December 2013
Torrent to buy Elder’s India, Nepal business for Rs2,000 crore
13 December 2013
Venus Remedies signs pact with South Africa’s Austell for marketing antibacterial drug
09 December 2013
US firm Mylan buys out Stride Arcolab’s injectables unit
06 December 2013
No non-compete clause in pharma sector takeovers: govt
02 December 2013
Cabinet refuses to peg pharma sector FDI at 49%
29 November 2013
US buyout firm KKR to invest $200 mn in Gland Pharma
28 November 2013
Biocon, Mylan get approval for biosimilar cancer drug Trastuzumab
28 November 2013
US group opposes Gilead’s patenting of hepatitis C drug in India
25 November 2013
Pfizer India and Wyeth Ltd to merge Indian operations
25 November 2013
Government to review FDI policy in pharma, realty
23 November 2013
PE firms in fray for critical care biopharma firm Ikaria
23 November 2013
Torrent Pharma in advanced talks to buy Elder Pharma’s local business for Rs2,000 crore
22 November 2013
JLL Partners and Royal DSM to create new pharma firm in a $2.6 bn deal
19 November 2013
US FDA warns Medtronic's recalled guidewires could cause death
18 November 2013
Commerce ministry bats for limiting pharma FDI at 49%
15 November 2013
Sun Pharma Q2 net jumps four-fold to Rs1,362 crore
14 November 2013
Chilean drug maker CFR threatens to withdraw $1.3 bn bid for Adcock Ingram
12 November 2013
Novartis to sell blood transfusion testing unit to Spain's Grifols for $1.675 bn
12 November 2013
Daiichi Sankyo accuses Singh brothers of concealing facts during Ranbaxy acquisition
12 November 2013
Crestview Partners puts surgical facilities operator Symbion for sale: report
09 November 2013
Boehringer Ingelheim in the race to buy Lohmann Animal Health
09 November 2013
Salix Pharmaceuticals to buy Santarus for $2.6 billion
08 November 2013
Danaher, Blackstone Group jointly bid for Johnson & Johnson's diagnostics unit
08 November 2013
Endo Health to buy Canada's Paladin Labs in $1.7-bn deal
06 November 2013
Mis-selling of drugs to cost J&J $2.2 bn in US settlement
05 November 2013
Roche to pay $458 mn for rights to experimental antibiotic
05 November 2013
General Atlantic seeks $1.1 bn from sale of German laboratory-service provider Amedes Group
01 November 2013
China’s Fosun Pharma to sell two drugs to Switzerland’s Sellas Clinicals for $534 mn
24 October 2013
McKesson Corp buying German drugs distributor Celesio in $8.3-bn deal
24 October 2013
McKesson nears deal to buy German drugs distributor Celesio for €23 per share
24 October 2013
Wockhardt faces fresh strictures from UK drug regulator
23 October 2013
Reckitt Benckiser prepares to sell pharmaceuticals unit
23 October 2013
Actis invests Rs294 crore in Indore's Symbiotec Pharmalab
23 October 2013
Wockhardt recalls 5 drugs in UK after regulatory strictures
19 October 2013
Hungary, India sign pact to promote Ayurveda
18 October 2013
Zydus, Germany’s Pieris tie up to develop `Anticalin’ protein drugs
16 October 2013
Wockhardt gets another slap from UK drug regulator
14 October 2013
German nicotine-patch maker LTS Lohmann receives several bids
12 October 2013
KKR & Co to buy 30% in Gland Pharma for Rs920 crore: report
11 October 2013
Teva Pharmaceutical to cut 5,000 jobs, save $2 bn annually
11 October 2013
McKesson in advanced talks to buy German drugs distributor Celesio for $5.08 bn
08 October 2013
Indigenous vaccine for Japanese encephalitis launched
05 October 2013
US biopharmaceutical company Ikaria Inc explores sale
04 October 2013
Avista Capital and Nordic Capital to buy Swiss generic drugmaker Acino for $439 mn
03 October 2013
Astex Pharma $886-mn merger with Japan’ Otsuka runs into shareholder trouble
03 October 2013
PE firms in race for J&J’s Ortho Clinical Diagnostics unit
01 October 2013
GSK sells thrombosis drugs to Aspen for $1.13 billion
01 October 2013
Supreme Court bans all drug trials for lack of monitoring mechanism
30 September 2013
Wockhardt gets another blast from US drug regulator FDA
28 September 2013
Actavis agrees to sell some generic drugs for regulator nod on Warner Chilcott deal
28 September 2013
US regulator puts conditions on Mylan’s $1.6 bn acquisition of Arcolab’s Agila unit
27 September 2013
US medical device maker Stryker Corp to buy Mako Surgical for $1.65 bn
26 September 2013
Apollo, Saarum Innovations team up to set up biobank
24 September 2013
Ablynx in $840-mn drug licensing deal With AbbVie
23 September 2013
Roche denies raising money to acquire BioMarin Pharmaceuticals
20 September 2013
Southeast Asian generics market to reach $3.9 bn by 2016
16 September 2013
Sanofi, Shire eye US rare diseases drug maker ViroPharma
14 September 2013
S African drug maker Adcock Ingram approves Chile’s CFR $1.3-bn bid
12 September 2013
Roche in exclusive cancer vaccine development deal with Inovio Pharmaceuticals
11 September 2013
KKR & Co may invest Rs1,000 cr in Hyderabad-based Gland Pharma
10 September 2013
J&J launches sale of Ortho Clinical Diagnostics unit
07 September 2013
Japan’s Otsuka Holdings to pay $886 mn for cancer drug maker Astex Pharma
06 September 2013
US medical device maker C R Bard to acquire Rochester Medical for $262 mn
05 September 2013
FIPB clears US drug maker Mylan’s deal to buy Strides Arcolab arm
28 August 2013
Amgen to acquire cancer drug maker Onyx for $10.4 bn
26 August 2013
German generic drugmaker Stada to buy UK’s Thornton & Ross
17 August 2013
Amgen's $9.5-bn Onyx deal stumbles over cancer drug data
16 August 2013
Mylan gets PMO nod to acquire Agila Specialities
16 August 2013
CFR’s $1.3-bn bid remains best offer for Adcock Ingram
16 August 2013
Rexam starts selling $1 bn healthcare packaging unit
14 August 2013
Sanofi becomes latest drug firm under Chinese probe for bribery
12 August 2013
Sun Pharma does well, but Pfizer settlement puts it in red
10 August 2013
Govt extends validity of duty exemption for drug firms complying with price ceiling
08 August 2013
Amgen said to raise bid for Onyx Pharma to $130 a share
07 August 2013
SC slams government for poor drug pricing policy
07 August 2013
German generic drugmaker Stada in talks to buy UK’s Thornton & Ross
06 August 2013
Nova Diabetes Care recalls 62 mn faulty glucose test strips
02 August 2013
India revokes patent of GSK’s breast cancer drug Tykerb
02 August 2013
KKR & Co to buy ReSearch Pharmaceutical from PE firm Warburg
01 August 2013
US biopharma firm Cubist to buy pharma firms Trius, Optimer in $1.60-bn deal
31 July 2013
US drugmaker Perrigo buys Irish biotechnology major Elan for $8.6 bn
30 July 2013
Pfizer plans separate segments for brands, innovations and generics
29 July 2013
GSK to pay $229 mn to eight US states to settle diabetes drug Avandia lawsuits
25 July 2013
Pharma giants target biotech firm Onyx
23 July 2013
Chilean drugmaker CFR to raise $750 mn to fund Adcock Ingram acquisition
23 July 2013
EU regulator conditionally approves Baxter’s $4-bn Gambro acquisition
23 July 2013
Bain Capital buys majority stake in Plasma Resources UK for $349 mn
19 July 2013
Abbott to enter laser cataract surgery market through OptiMedica acquisition
16 July 2013
China detains four senior GSK employees over bribery
15 July 2013
Sun Pharma gets US nod to sell generic diabetes drug
13 July 2013
Swiss drugmaker Roche eyes Alexion Pharmaceuticals
13 July 2013
Anand Sharma seeks review of pharma sector FDI policy
12 July 2013
British drug regulator recalls 16 Wockhardt drugs
11 July 2013
China accuses GSK of bribery, raising prices and tax fraud
11 July 2013
Ranbaxy to pay $0.42 million fine for sub-standard drugs sold in US
09 July 2013
GSK signs next-generation cancer drugs development deal with Immunocore
09 July 2013
Russia's biggest drugmaker Pharmstandard to spin off OTC business
09 July 2013
GSK probes whether employees bribed doctors in China to prescribe Botox
08 July 2013
DIPP throws spanner in 100% pharma sector FDI plan
06 July 2013
China launches probe on GSK over price fixing
05 July 2013
S Africa’s Adcock Ingram receives $1.3-bn bid from Chile’s CFR Pharma
04 July 2013
Sale of Turkish pharmaceutical company Sanovel may fetch upto $1 bn
03 July 2013
Swiss drugmaker Roche buys US blood testing company CMI for $220 mn
02 July 2013
Biotechnology company Onyx rejects Amgen’s $10 -bn takeover bid
01 July 2013
Diclofenac painkiller linked to heart attack, stroke: study
29 June 2013
Amgen eyes $10-bn cash deal with Onyx Pharmaceuticals: report
29 June 2013
Germany’s Fresenius sells biotechnology business to Israel’s Fuhrer family
28 June 2013
Russian biotechnology firm Biocad seeks buyers: report
27 June 2013
Aspen Pharmacare to buy API business from Merck in $1 billion deal
27 June 2013
LifeLabs Medical Laboratory to buy CML HealthCare for $1.16 bn
25 June 2013
Russia's Pharmstandard mulls selling OTC business: report
25 June 2013
KKR & Co acquires clinical research group PRA for a reported $1.3 bn
25 June 2013
SC throws out PIL against Ranbaxy over substandard drug issue
25 June 2013
European regulator fines Ranbaxy and 8 others for blocking generic drugs
19 June 2013
Glenmark receives US health regulator approval for Riluzole tablets
19 June 2013
Aspen Pharma offers to buy GlaxoSmithKline’s thrombosis brands
18 June 2013
J&J to buy Aragon Pharmaceuticals; deal potential $1 bn
17 June 2013
Elan shareholders approve share-repurchase program jeopardising Royalty’s bid
17 June 2013
No patents on human DNA, unless synthetic: US Supreme Court
14 June 2013
Zydus US subsidiary to recall one lot of Warfarin blood thinner in US markets
13 June 2013
Sun Pharma settles Teva patent spat with Pfizer for $550 mn
13 June 2013
Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit
12 June 2013
Six private, PSU firms keen to buy Haldia Petrochem stake
11 June 2013
Elan Corp rejects increased offer from Royalty Pharma
10 June 2013
AstraZeneca to acquire respiratory drug company Pearl Therapeutics in $1.15 bn deal
10 June 2013
Canada’s Valeant backs out from buying Serbia’s Galenika Pharmaceuticals
08 June 2013
Apollo Pharma reviewing sale of Ranbaxy drugs, but no ban yet
08 June 2013
Battle for Elan intensifies as Royalty Pharma raises bid to $6.7 bn
08 June 2013
RPG Life Sciences sells surplus land in Navi Mumbai to Maruti Suzuki
07 June 2013
Cinven, KKR, Warburg to place second-round bids for PRA
05 June 2013
AstraZeneca's withdrawal of drug from regulatory tests hits partner Rigel's shares
05 June 2013
Government sees plot to malign India’s pharma industry
03 June 2013
Dr Reddy’s, Fuji Corp terminate Japan partnership deal
03 June 2013
Sun Pharma in discussion to acquire controlling stake in Meda AB
31 May 2013
Drug pricing mechanism to impact near term pharma sector revenues
30 May 2013
GlaxoSmithKline to buy Swiss biotech firm Okairos
29 May 2013
Amgen to form Japanese venture with Astellas Pharma
29 May 2013
Indian doctors’ body asks DCGI to probe Ranbaxy drug quality
29 May 2013
Wockhardt reports consolidated Q4 net profit of Rs334.767 crore
28 May 2013
AstraZeneca to acquire Omthera Pharmaceuticals in $443 mn deal
28 May 2013
Valeant to acquire Bausch & Lomb for $8.7 bn
27 May 2013
Canada’s Valeant in talks to buy Bausch & Lomb for $9 bn
25 May 2013
Ireland’s Elan rejects Royalty Pharma’s sweetened $6.4 bn bid
24 May 2013
Daiichi admits Ranbaxy hid info from US drug regulators
23 May 2013
UK’s specialty pharma firm BTG spends $380 million on two acquisitions
23 May 2013
Pfizer to spin-off rest of animal health unit Zoetis to shareholders
22 May 2013
Drugs found to both prevent and treat Alzheimer’s in mice
22 May 2013
Merck & Co to buy back $5-bn worth stock
22 May 2013
3i makes a 2.3x return on the sale of Xellia
21 May 2013
Denmark’s Novo A/S acquires Xellia Pharmaceuticals for $700 mn
21 May 2013
Royalty Pharma raises offer to $6.4 bn for Irish drugmaker Elan
21 May 2013
Actavis to acquire Irish specialty drug maker Warner Chilcott for $5 bn
20 May 2013
Irish drugmaker Elan splurges $380 mn on two acquisitions
20 May 2013
Bayer AG to acquire herbal drug maker Steigerwald Arzneimittelwerk
17 May 2013
Actavis rejects Mylan’s $15-bn offer
15 May 2013
Ranbaxy fined $500 mn by US regulator over drug safety lapses
14 May 2013
China continues to push fake drugs and food products into Nigeria
11 May 2013
Actavis in talks to buy Ireland’s Warner Chilcott
11 May 2013
US medical device provider ICU Medical weighs $1 bn sale: report
09 May 2013
IISc develops novel drug delivery device
08 May 2013
China’s Fosun Pharma to buy majority stake in Israel’s Alma Lasers for $240 mn
08 May 2013
AstraZeneca site to emerge as biotech hub
08 May 2013
Johnson & Johnson recalls children’s Tylenol in South Korea
06 May 2013
Johnson & Johnson’s plant licence revoked on quality concerns
04 May 2013
Valeant Pharma's $13-bn Actavis deal put on hold
29 April 2013
Canada’s Valeant Pharma in talks to buy Actavis for over $13 bn
27 April 2013
After kickbacks to pharmacies, Novartis now sued for bribing US docs
27 April 2013
US government sues Novartis for paying kickbacks to pharmacies
24 April 2013
Opko Health to acquire Israel’s Prolor Biotech for $480 mn
24 April 2013
Chinese biotechnology firm 3SBio receives sweetened offer from CEO
23 April 2013
AstraZeneca in $200-mn cancer drug development deal with Bind Therapeutics
22 April 2013
Russia blocks Abbott Laboratories - Petrovax merger
20 April 2013
GAVI, Biological Evans in pact to lower cost of pentavalent vaccine
19 April 2013
GSK accused of paying off rivals to delay entry of generic drugs
19 April 2013
Orchid Chemicals inks antibiotics development pact with Europe’s Allecra Therapeutics
18 April 2013
Cipla launches first biosimilar drug for rheumatic disorders
17 April 2013
Thermo Fisher nears $12.8-bn takeover of Life Technologies: report
15 April 2013
Shareholders of Irish drug maker Elan approve $1 bn buyback
13 April 2013
Eli Lilly to lay off around 1,000 sales personnel in US
12 April 2013
India-EU free-trade pact may undermine WTO’s patent agreement
10 April 2013
GVK BIO licences out its SAR database to Scottish drug discovery body
10 April 2013
Germany's Merz Pharma withdraws bid for Obagi Medical Products
08 April 2013
AstraZeneca’s rheumatoid arthritis pill fostamatinib shows mixed results in trial
08 April 2013
Drug firms paid UK doctors £40 million for travel and expenses: Pharma industry body
06 April 2013
Delhi HC refuses interim relief to Merck over Glenmark drug
05 April 2013
Astellas in oncology antibody drug pact with Ambrx
05 April 2013
Valeant Pharma outbids Merz for control of Obagi Medical Products
04 April 2013
Pfizer, Novartis, Abbott in race for Brazil’s Ache Laboratorios: report
03 April 2013
SC ruling on Novartis patent disappoints US Inc; but NGOs cheer
03 April 2013
Novartis loses patent battle in SC over cancer drug Glivet
01 April 2013
Novartis AG will cut stake in Indian arm to meet SEBI norms
28 March 2013
Novartis expects ‘negative’ SC verdict in Glivet patent case
28 March 2013
AstraZeneca settles Crestor lawsuit with Egis and Actavis
25 March 2013
S Africa’s Bidvest to raise stake in drugmaker Adcock Ingram to 60%
23 March 2013
Valeant Pharmaceuticals to acquire Obagi Medical Products for $344 mn
21 March 2013
AstraZeneca to eliminate 1,600 jobs in major R&D restructuring
19 March 2013
First Chinese pharma firm fined for price fixing in the US
18 March 2013
US cosmetic laser manufacturer Cynosure to buy rival Palomar Medical
18 March 2013
DRL founder-chairman Anji Reddy passes away
15 March 2013
KKR consortium to bid for gene-sequencing equipment maker Life Technologies: report
12 March 2013
Chinese generic drugmaker Simcere receives $500-mn bid from chairman
11 March 2013
Abbot spinoff AbbVie files to block EU regulator from releasing clinical trials data
11 March 2013
J&J to pay $8.3 mn for hip-implant metal poisoning in first of 11,000 lawsuits
09 March 2013
Pfizer files patent-infringement suits against Lupin, four others
06 March 2013
Par Pharmaceutical to pay $45 mn to settle Megace ES drug off-label charges
06 March 2013
US FDA disallows Ranbaxy's Indian-manufactured generic Lipitor in US
05 March 2013
Bayer loses cancer drug patent case
04 March 2013
Cipla amends offer, offers $512 mn for whole of Cipla Medpro South Africa
28 February 2013
Strides Arcolab sells Agila Specialties to Mylan for $1.6 bn
28 February 2013
FDA turns down Reckitt's bid to block rival products
27 February 2013
Royalty Pharma launches $6.6 bn bid for Irish drug maker Elan Corp
26 February 2013
Ranbaxy to restart production of generic version of cholesterol-lowering drug Lipitor
25 February 2013
GSK Pharma net up at Rs138.5 cr; proposes 500 per cent dividend
19 February 2013
Unichem to sell Madhya Pradesh formulation facility to Mylan for Rs160 crore
16 February 2013
Merck to pay $688 mn to settle anti-cholesterol drug Vytorin lawsuits
15 February 2013
Andhra HC quashes tax demand on Sanofi over Shantha Biotech buyout
15 February 2013
GSK among others mulling upto $4-bn bid for Brazilian drugmaker Ache Laboratorios
13 February 2013
Bristol-Myers Squibb enters $482-mn Latin American deal with Reckitt Benckiser
12 February 2013
Dr Reddy's acquires 93 % shares of OctoPlus; extends offer till 26 February
12 February 2013
US generic drug maker Perrigo acquires Rosemont Pharmaceuticals
12 February 2013
Cipla Ltd puts $220-mn bid for South African generic drug maker on hold
12 February 2013
Sun Pharma calls off $600-million buyout of Taro
08 February 2013
CVS Caremark buys Brazilian drugstore chain Drogaria Onofre
07 February 2013
Biogen Idec to pay Elan Corp $3.25 bn plus for full rights of multiple sclerosis drug Tysabri
06 February 2013
GSK ups stake in Indian arm to 72.5% in a Rs4,800-cr stock deal
05 February 2013
AstraZeneca chief hints at changes with adverse outlook as patents expire
02 February 2013
Bristol-Myers Squibb may sell some brands in Mexico, Brazil: report
01 February 2013
GVK BIO Enters into Research Collaboration with Endo Pharmaceuticals
28 January 2013
Johnson & Johnson weighs sale of Women's Health division: report
28 January 2013
Allergan to buy adult migraine treatment drug maker MAP Pharmaceuticals for $958 mn
23 January 2013
US medical device maker Stryker to acquire Hong Kong-based Trauson for $764 mn
17 January 2013
Pfizer eyes Strides Arcolab’s injectables unit Agila Specialties: report
15 January 2013
Merck to recall good HDL cholesterol drug Tredaptive
12 January 2013
Biocon receives marketing authorisation for psoriasis drug
08 January 2013
Illumina to buy Down's syndrome test maker Verinata Health in a $450 mn deal
08 January 2013
Humans are not guinea pigs, SC tells govt
03 January 2013
Dr Reddy’s Lab sued for patent infringement in US
27 December 2012
Carlyle to sell Japanese drug capsule maker Qualicaps to MCHC for $660 million
26 December 2012
Illumina reportedly agrees to Roche's $8.2-bn takeover offer
21 December 2012
Abbott introduces bio-absorbable drug eluting vascular scaffold for cardiac use
19 December 2012
Mumbai's Transasia acquires Drew Scientific, JAS Diagnostics Inc
19 December 2012
Sun Pharma to buy some generic business of Takeda's US subsidiary URL Pharma
18 December 2012
New EU drug export rule likely to hit pharma exports
13 December 2012
National Pharmaceutical Pricing Policy, 2012 to replace DPCO
12 December 2012
Amgen to buy Decode Genetics for $415 million
11 December 2012
GSK, MD Anderson Cancer Center to develop new cancer drugs
10 December 2012
Claris transfers infusions business to JV with Japanese cos for Rs1,050 crore
08 December 2012
Wipro to acquire Singapore’s LD Waxson Group for Rs790 crore
08 December 2012
Sanofi still in the race for Bayer’ blood glusose testing business: report
08 December 2012
Top US court to rule on pact among pharma firms to delay generics launch
08 December 2012
Strides Arcolab, Eli Lilly to collaborate on cancer drug delivery
05 December 2012
Baxter International to buy Swedish dialysis product company Gambro for $4 bn
04 December 2012
Nestle forms JV with Li Ka-Shing’s Chi-Med for developing gastro treatment based on traditional Chinese medicine
29 November 2012
AstraZeneca loses appeal on lung cancer drug rights in India
28 November 2012
Smith & Nephew to buy privately-held Healthpoint for $782 million
28 November 2012
67-year old Mumbai patient implanted with the first MRI compatible CRT-D in India
27 November 2012
Ranbaxy recalls generic Lipitor in US market over glass particles in bottles
24 November 2012
Pfizer cuts Viagra price in Canada after losing patent case
23 November 2012
Essential drug prices to fall as GoM approves new pricing policy
22 November 2012
Cipla offers to acquire controlling stake in Cipla Medpro South Africa for $220 million
21 November 2012
Novartis receives FDA approval to make first cell-culture vaccine in US for seasonal influenza
21 November 2012
Bayer backs out from bidding war with Reckitt Benckiser over US vitamins maker Schiff Nutrition
20 November 2012
Canadian life sciences company SQI Diagnostics explores sale
20 November 2012
Allergan to buy SkinMedica’s skin care unit for $350 million
19 November 2012
GVK BIO sets up India's largest lsotope labeling facility
19 November 2012
Biocon in pact with Bristol-Myers Squibb for oral insulin
16 November 2012
Sun Pharma to buy US dermatology company Dusa Pharmaceuticals for $230 mn
09 November 2012
Boston Scientific to buy Vessix Vascular in a $425 million deal
09 November 2012
Cipla slashes prices of three more cancer drugs
08 November 2012
Astex Pharmaceuticals in drug discovery pact with Cancer Research Technology, Newcastle University
31 October 2012
Biocon announces positive results from its global phase 3 study with recombinant human insulin
31 October 2012
GE Capital to invest Rs125 crore in Biocon’s subsidiary Syngene International
31 October 2012
Allergan explores sale of obesity intervention business
31 October 2012
Bayer to buy US vitamins maker Schiff Nutrition International for $1.2 bn
30 October 2012
Japan’s Shionogi & Co to take 10% in GSK-Pfizer HIV joint venture Viiv Healthcare
29 October 2012
Pfizer to buy ADHD drug maker NextWave Pharma for $255 mn
22 October 2012
Dr Reddy's Laboratories to acquire Dutch specialty pharmaceutical firm OctoPlus for €27.4 mn
22 October 2012
European PE firm acquires pharmaceutical company Amdipharm for $590 million
15 October 2012
SC asks centre, states to explain “illegal” human drug trials
08 October 2012
Takeda Pharmaceutical ties-up with Tata Group's Advinus Therapeutics
04 October 2012
Government proposes free supply of essential medicines: Azad
03 October 2012
SC rejects govt’s new drug pricing proposals
03 October 2012
Sanofi to acquire Colombian affordable drugmaker Genfar
03 October 2012
NGO to challenge drug price control over lacunae
29 September 2012
Government to cap prices of essential drugs
28 September 2012
Sony to acquire 11 % in Olympus, to set up JV to develop endoscope equipments
28 September 2012
Medtronic to acquire orthopaedic device maker China Kanghui for $816 mn
28 September 2012
Canada’s Valeant Pharma acquires QLT’s Visudyne for over $112.5-mn
25 September 2012
Biocon among top 20 employers in sector: survey
25 September 2012
PE firm Advent to buy Dutch pharmacy chain Mediq for $1.01 bn
24 September 2012
Mitsui’s stake buy in Arch Pharma gets CCI nod
22 September 2012
Boston Scientific to acquire heart device maker BridgePoint Medical
20 September 2012
Druggists ask Sharad Pawar to speed up National Pharmaceutical Pricing Policy decision
18 September 2012
Alliance Boots to buy 12% in China’s Nanjing Pharmaceutical for $88 million
17 September 2012
Bayer HealthCare to buy Teva Pharma' US animal health business for$145 mn
14 September 2012
Ranbaxy to invest $40 million to set up a second plant in Malaysia
13 September 2012
Supreme Court asks Novartis to cut price of Glivec
13 September 2012
Government approves 8 new pharma FDI proposals worth Rs1,843 crore
11 September 2012
Glivec is `special’, Novartis argues in Supreme Court
11 September 2012
Dr. Reddy’s Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets
11 September 2012
USFDA approves Aurobindo Pharma's hypertension drugs
07 September 2012
Hiring freeze in pharma industry expected: survey
06 September 2012
Canada’s Valeant to acquire Medicis Pharmaceutical for $2.6 bn
04 September 2012
German maker of thalidomide apologises, after 50 years
01 September 2012
Medical technology firm ConvaTec to buy 180 Medical Holdings for $321 mn
01 September 2012
J & J to pay $181 million to settle Risperdal's illegal marketing claims
31 August 2012
Genmab in $1.1-bn onco drug licencing deal with Johnson & Johnson
30 August 2012
Orchid sells API, R&D unit to Hospira for Rs1,113 crore to reduce debt
30 August 2012
Sun Pharma gets partial US FDA clearance to resume US operations
29 August 2012
Aetna to buy Coventry Healthcare in $5.7-bn deal
22 August 2012
Wockhardt to launch generic hypertension drug in US
21 August 2012
GSK to sell Australian generic portfolio to Aspen Pharma
16 August 2012
Grand Slam Asset Management rejects Sun Pharma’s sweetened offer for Taro
14 August 2012
Pfizer files IPO for animal health unit Zoetis Inc
14 August 2012
Sun Pharma to buy out Israel’s Taro for $571 million
13 August 2012
Sun Pharma to spin off domestic formulations business into Sun Resins & Polymers
11 August 2012
AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights
10 August 2012
Warner Chilcott scraps sale plans; to pay $1 billion dividend
08 August 2012
Pfizer to pay $60 mn to settle US bribery charges
08 August 2012
BC Partners to buy German generic drugs maker Aenova for $618 mn
07 August 2012
Teva Pharmaceutical under US scanner for bribing officials in Latin America
06 August 2012
Sun Pharmaceuticals eyes German generic-drug maker Stada: report
03 August 2012
Ranbaxy in licensing pact with Gilead for HIV drug
03 August 2012
European regulator charges Teva, Lupin and Unichem for blocking perindopril
30 July 2012
US FDA lifts import alert from Dr. Reddy’s Mexican chemical manufacturing facility
30 July 2012
Astellas in tropical disease research pact with Japanese reserach body
30 July 2012
GVK says Ahmedabad bioscience's unit successfully clears US FDA audit
30 July 2012
India weighing price controls on patented drugs
27 July 2012
Wockhardt completes divestment of nutrition business to Danone
26 July 2012
Israel’s Teva, P&G tie up to set up plant in Gujarat
25 July 2012
Panel may cap pharma sector FDI through automatic route at 49 per cent
23 July 2012
Cipla, DNDi to jointly develop new drug for HIV-positive infants
21 July 2012
Germany’s Fresenius to buy US blood collection equipment maker Fenwal Holdings
21 July 2012
Israel’s Taro rejects Sun Pharma’s $367-mn buyout offer
20 July 2012
Strides Arcolab arm gets USFDA approval for anti-cancer drug
19 July 2012
UN report points to falling AIDS infection in children
19 July 2012
India's role in AIDS control commended
19 July 2012
Biocon plans merger with biopharma subsidiary
18 July 2012
USFDA revokes warning to Cadila Healthcare
17 July 2012
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 July 2012
TPG Capital to acquire Par Pharmaceutical for $1.9 billion
16 July 2012
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 July 2012
Finoso Pharma forms equal JV with US-based CritiTech
13 July 2012
Bristol-Myers Squibb launches tender offer for Amylin
12 July 2012
Strides Arcolab forms JV with Canada’s Jamp Pharma
11 July 2012
South Africa's Adcock Ingram to buy Cosme Farma drug business for Rs480 crore
11 July 2012
Fortis, GE set up Asia's first remote intensive care units at Raipur, Dehradun
07 July 2012
Lupin receives US FDA approval for generic diabetic drug
05 July 2012
Seven pharma firms in pact to speed TB drug discovery.
05 July 2012
Tamil Nadu’s Rs92,160-cr petrochemicals zone gets CCEA nod
05 July 2012
Serum Institute buys Netherlands's Bilthoven Biologicals for $40 million
04 July 2012
Government to set up fund for pharma R&D
04 July 2012
GlaxoSmithKline to pay record $3 billion in US drug fraud case
03 July 2012
Dr. Reddy’s announces the launch of Ibandronate Sodium tablets
02 July 2012
Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition
30 June 2012
Shire shares plunge after regulators back copycat version of Adderall
27 June 2012
India keen to invest in Russia’s pharma sector Anand Sharma
21 June 2012
Merck & Co in talks to buy Bangalore-based Micro Labs: report
21 June 2012
Daiichi Sankyo to market Ranbaxy drugs in Venezuela
20 June 2012
Valeant Pharmaceuticals to buy OraPharma for $312 million
15 June 2012
J&J gets final US nod for $19.7-bn Synthes acquisition
14 June 2012
India, Brazil to cooperate in production of essential drugs
12 June 2012
Venus Remedies develops antibiotic for `super bugs', receives US patent
12 June 2012
GSK to buy new eczema drug Toctino from Basilea Pharmaceutica for £146 mn
12 June 2012
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 June 2012
Johnson & Johnson to set aside $600 mn for Risperdal lawsuits settlement
09 June 2012
Sandoz recalls Introvale birth control pills over packaging error
08 June 2012
Cipla loses appeal in US federal court in pet drug case
07 June 2012
Lawsuits spur J&J to stop sales of vaginal mesh implants
06 June 2012
Dr. Reddy’s Laboratories, Merck Serono to develop biosimilars
06 June 2012
Aurobindo Pharma rejigs execs in wake of ‘Jagan scam’
31 May 2012
Shanghvi steps down as Sun Pharma chairman; Israel Makov to take over
30 May 2012
Pressure on govt panel to put more drugs under price control
21 May 2012
Dr. Reddy’s, Sun Pharma, 9 others get FDA nod for generic version of Plavix
19 May 2012
Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid
18 May 2012
India must leverage its strengths to spur biopharma Innovation
12 May 2012
Cipla to slash prices of six more cancer drugs
11 May 2012
US FDA grants final approval to Strides' injectible acetazolamide
10 May 2012
Japan’s GC Corp, Unison Capital to buy drugmaker Showa Yakuhin Kako
09 May 2012
GlaxoSmithKline goes hostile with its $2.59-bn bid for Human Genome Sciences
09 May 2012
Zydus Cadila in talks to acquire Strides Arcolab's domestic generic business?
09 May 2012
Abbott to pay $1.6 bn to settle Depakote epilepsy drug suits
09 May 2012
Bayer appeals against grant of ‘Nexavar’ licence to Natco
07 May 2012
Abbott collaborates with Syngene to open first nutrition research centre in India
05 May 2012
Dutch life sciences company DSM launches $360-mn bid for US firm Kensey Nash
04 May 2012
Cipla slashes prices of three key cancer drugs
03 May 2012
China sales, Singulair drive Merck’s Q1-2012 net to $3 bn
28 April 2012
German health care firm Fresenius launches $4.09 bn bid for rival Rhoen-Klinikum
26 April 2012
Watson Pharmaceuticals to buy Swiss rival Actavis for $5.60 billion
26 April 2012
Strides acquires US FDA-approved Sterile Formulations facility
26 April 2012
Amgen to buy Turkey’s Mustafa Nevzat Pharmaceuticals for $700 mn
26 April 2012
Ranbaxy launches India's first new drug for malaria, Synriam
25 April 2012
AstraZeneca buys US biotech firm Ardea for $1.26 bn
24 April 2012
Baxter to set up $1-bn plant for plasma-based therapies
21 April 2012
Aspen to buy GSK’s international OTC brands
20 April 2012
Johnson & Johnson’s $21 billion bid for Synthes gets EU nod
19 April 2012
GlaxoSmithKline’s $2.6-bn bid rejected by Human Genome Sciences
19 April 2012
Roche ends $6.7-bn hostile bid for Illumina
19 April 2012
Piramal Healthcare buys Bayer’s molecular imaging and research portfolio
16 April 2012
Piramal Healthcare gets EU approval for its regenerative product `BST-CarGel’
11 April 2012
Japan’s Takeda Pharmaceutical to acquire URL Pharma for $800 million
11 April 2012
ISS backs Illumina board; urges rejection of Roche's $6.7-bn bid
07 April 2012
Letter to Roche from Illumina’s president and CEO
03 April 2012
Illumina rejects Roche’s $6.7-bn bid
03 April 2012
Sanofi acquires US animal vaccines specialist Newport Laboratories
03 April 2012
Dow Chemicals to eliminate 900 jobs, shutter four plants
02 April 2012
Forest Laboratories buys hypertension drug rights from J&J for $357 mn
02 April 2012
Ranbaxy begins US exports of generic Lipitor from Mohali
02 April 2012
Amylin reportedly rejects Bristol-Myers $3.5-bn bid
30 March 2012
Roche increases hostile offer for Illumina to $6.7 billion
29 March 2012
Columbia University sues Illumina over patent infringement
27 March 2012
Bausch & Lomb to acquire Ista Pharmaceuticals for $500 million
27 March 2012
Canada's Valeant Pharmaceuticals to acquire Russia’s Natur Produkt for $180 mn
27 March 2012
Watson Pharmaceuticals close to buying Actavis for around $7 bn: report
22 March 2012
Roche asks Illumina investors to accept its $5.7-bn bid
21 March 2012
Covidien to buy Israeli medical device maker superDimension for $300 mn
20 March 2012
Sanofi to acquire US medical device company Pluromed to expand in biosurgery
16 March 2012
GSK to sell most European OTC drugs to Omega Pharma
15 March 2012
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 March 2012
Natco granted compulsory licence for Bayer's Nexavar
12 March 2012
Ranbaxy opens new manufacturing facility in Morocco
12 March 2012
Asahi Kasei makes $2.2-bn bid for Zoll Medical
12 March 2012
Boston Scientific to acquire Cameron Health in a potential $1.35-bn deal
09 March 2012
Ranbaxy launches cholesterol-lowering drug `Atorvastatin’ in Europe
06 March 2012
Dr Reddy’s launches schizophrenia drug `ziprasidone hydrochloride’ capsules In US
03 March 2012
Japan's Dainippon Sumitomo to acquire Boston Biomedical for $200 mn
01 March 2012
Australia’s Rapid Nutrition to acquire 74 % stake in Cheminnova Remedies
29 February 2012
Roche extends hostile $5.7-billion offer for Illumina
27 February 2012
Danone, Mead Johnson team up against Nestle for Pfizer's $10-bn infant nutrition
25 February 2012
Ranbaxy may hand over Latin American marketing to Daiichi Sankyo
25 February 2012
Ranbaxy reports Rs2,983 crore Q4 loss on US probe provisioning
23 February 2012
Ananda Krishnan, Malaysia's second-richest man, to sell power portfolio worth $2 bn
23 February 2012
J&J offers EU concessions for $21.3 bn takeover of medical device firm Synthes
23 February 2012
Mexico’s Genomma to buy Prestige Brands for $834 million
22 February 2012
Ranbaxy launches generic version of cholesterol-lowering drug Lipitor in Australia
21 February 2012
Pfizer, China’s Zhejiang to form $545 million JV for generic medicines
20 February 2012
Pfizer mulls $3 billion partial IPO for animal healthcare unit: report
20 February 2012
Wyeth Pharma seeks damages of $960 million over Protonix drug patent dispute
16 February 2012
Rejected in the US, J&J sells hip implant overseas
16 February 2012
Merck, Brazil’s Supera Farma to form JV for generic drugs
16 February 2012
Pharma company Aptuit Laurus raises Rs200 cr from Fidelity Growth Partners
14 February 2012
Valeant to acquire Macugen anti-VEGF inhibitor maker Eyetech Inc
14 February 2012
Illumina rejects Roche's $5.7- bn hostile bid
08 February 2012
GSK repatriating funds daily from European operations
08 February 2012
Daiichi Sankyo seeks to buy three mid-sized Indian pharma firms: report
07 February 2012
Merck to pay Threshold up to $525 million for cancer drug development
06 February 2012
AstraZeneca eliminates 7,300 jobs in major restructuring
03 February 2012
Pfizer recalls 1 million birth-control pills
01 February 2012
Roche Diagnostics plans Jafza headquarters for Middle East
30 January 2012
Outlook for pharmaceutical in 2012 stable, says Fitch
30 January 2012
Amgen to buy leukemia drug developer Micromet for $1.16 billion
27 January 2012
Watson acquires Strides Arcolab’s Australian generic unit for Rs1,983 crore
24 January 2012
Dishman Pharma acquires French contract research firm Creapharm Parenterals
17 January 2012
Valeant Pharmaceuticals raises offer for opthalmic drugs maker ISTA
17 January 2012
Novartis restructures US operations, to cut 1,960 jobs
14 January 2012
Glenmark wins favourable interim order in deal with Napo
14 January 2012
Bristol-Myers to acquire hepatitis C oral drug developer Inhibitex for $2.5 bn
09 January 2012
Alexion Pharma to acquire Enobia for around $1.08 bn
29 December 2011
Zydus Cadila acquires Biochem Pharmaceuticals
21 December 2011
Medical device maker C R Bard acquires Lutonix
21 December 2011
Biocon arm Clinigene in pact with US company for speciality biomarkers
21 December 2011
Ranbaxy to pay $500 million to settle USFDA ban
21 December 2011
GSK to sell some North American OTC drugs to Prestige Brands for $661 mn
21 December 2011
Government extends sops for engineering, pharma and chemical exports
16 December 2011
Covidien plans to spin off pharmaceuticals business
16 December 2011
Glenmark to market Crofelemer despite Napo nix
15 December 2011
Pfizer battles dwindling Lipitor sales with hike in dividend, stock buy-back plan
13 December 2011
AstraZeneca to buy China’s generic maker Guangdong BeiKang Pharma
08 December 2011
AstraZeneca to cut 1,150 sales jobs in the US
08 December 2011
Ranbaxy to share Lipitor profits with Teva
02 December 2011
No immediate gain for Ranbaxy despite Lipitor patent's expiry
30 November 2011
Unlimited FDI in pharma sector worries Jena
30 November 2011
Merck to pay $950 million to settle Vioxx drug charges
24 November 2011
Pfizer to buy skin scarring drugmaker Excaliard Pharmaceuticals
23 November 2011
Gilead Sciences to acquire hepatitis C drug developer Pharmasset for $11 bn
21 November 2011
Canada's Valeant to acquire Australia's iNova Pharmaceuticals for $623 mn
21 November 2011
Pfizer to settle bribery charges with US government: report
21 November 2011
Pfizer's global health programme awarded Best International Ambassador award
19 November 2011
US FDA expert committee gives nod to the use of Pfizer’s Prevnar in adults
18 November 2011
Lupin to acquire Japan’s I'rom Pharmaceutical
17 November 2011
AB Sciex acquires Labindia's Mass Spectrometry unit to expand in India
14 November 2011
Drugmakers Otsuka, Lundbeck form global alliance for five drugs
11 November 2011
Pfizer, Ranbaxy sued over Lipitor price fixing in the US
10 November 2011
Mylan to acquire Pfizer’s generic version of Advair with inhaler technology
10 November 2011
Salix Pharmaceuticals to buy Oceana Therapeutics for $300 million
09 November 2011
GSK to pay $3 bn to settle US investigations for promoting drugs for unapproved uses
03 November 2011
Avesthagen sets up joint venture with Sava Medica to sell nutraceuticals
31 October 2011
European countries sign treaty to combat fake drugs
31 October 2011
Mylan launches first generic version of Novartis' dementia drug Exelon
27 October 2011
AstraZeneca - Bristol-Myers to present new data on diabetes drug
27 October 2011
Novartis to eliminate 2,000 jobs, close two sites in Europe
25 October 2011
Amgen sets aside $780 mn to settle lawsuits over improper sales of anemia drugs
25 October 2011
European regulator launches antitrust probe against Novartis and J&J
24 October 2011
Abbott to pay $1.3 bn to settle Depakote epilepsy drug claims
24 October 2011
Abott to split into two
19 October 2011
Sun Pharma to buy remaining stake in Israeli unit Taro for Rs1,810 crore
19 October 2011
Roche to buy hepatitis C drug developer Anadys for $230 million
18 October 2011
J&J unit wins lawsuit over antibiotic Levaquin drug side effects
15 October 2011
PE firms hire Citigroup to sell Japanese drugmaker Showa Yakuhin Kako
14 October 2011
Teva, Baxter and McKesson ordered to pay $162.5 million in damages over Propofol
11 October 2011
Mystery bidder withdraws from takeover battle for cancer drugmaker Allos
11 October 2011
Teva wins US regulatory approval for $6.8-bn Cephalon acquisition
08 October 2011
Medical diagnostics firm Axis-Shield bows to Alere’s raised offer of £235 mn
07 October 2011
Japan’s Holdings to buy US-based Caris Life Sciences for $725 million
07 October 2011
Carlyle, Hellman & Friedman to buy drug research firm PPD for $3.9 bn
05 October 2011
Government plans 6 more national centres for pharma education and research
01 October 2011
US FDA approves two new chemopathy drugs by Strides subsidiary Onco Therapies
30 September 2011
Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million
29 September 2011
Ipca Labs looks to acquire pharma unit in Indonesia
28 September 2011
Patented drugs overpriced, admits Glaxo CEO Witty
28 September 2011
JB Chemicals, Dr Reddy's call of Russia-CIS business deal
26 September 2011
Johnson & Johnson recalls anaemia drug Eprex in 17 countries
24 September 2011
New trial for retinal stem cell treatment approved
23 September 2011
Sun Pharma resolves FDA issue at US plant
19 September 2011
European drug regulator approves Strides' oncology injectible Oxaliplatin
16 September 2011
Jubilant arm in $70-million OTC drug manufacturing contract with US firm
14 September 2011
S Africa’s Aspen Pharma targets $800-mn foreign acquisitions
14 September 2011
India to emerge among top players in pharma industry by 2020
13 September 2011
Biocon to set biopharmaceutical plant, R&D centre in Malaysia
12 September 2011
Ranbaxy to launch generic ‘Lipitor’ in US by November
09 September 2011
Lupin, Sanofi-Aventis Philippines in strategic agreement
05 September 2011
Ranbaxy’s subsidiary launches esomeprazole in UK
05 September 2011
US drug standards agency expands testing facility in India
02 September 2011
Dr Reddy’s launches OTC generic of Sanofi's Allegra
31 August 2011
Cipla, Lupin deny in stake sale talks with Takeda
25 August 2011
Google settles Canadian pharma ad probe for $500 mn
25 August 2011
Aventis Pharma to acquire Universal Medicare in India
25 August 2011
Sanofi plans Rs450-cr OTC deal with Universal Medicare
23 August 2011
Biocon clinical arm, Spaulding of US in clinical trial partnership
22 August 2011
Medical devices maker ConvaTec outbids Apax for Kinetic Concepts: report
22 August 2011
Panacea loses drug contract with WHO over quality issues
19 August 2011
Ranbaxy introduces two-in-one painkiller 'Volini Duo' for OTC sales
12 August 2011
Ipca Labs buys UK-based Onyx Research Chemicals
09 August 2011
Glenmark files arbitration claims for Crofelemer against Napo
08 August 2011
British medical diagnostics firm Axis-Shield rejects Alere’s $375.4-million bid
05 August 2011
Hedge fund MSMB Capital launches $378-million takeover of Amag Pharma
04 August 2011
Venus Remedies' novel drug for 'superbug' granted US patent
03 August 2011
Danone to buy Wockhardt's nutrition business for Rs1,576 crore
03 August 2011
Merck & Co to axe 13,000 more jobs by 2015
30 July 2011
Eli Lilly ties up with Lupin to push diabetes drug sales
29 July 2011
Boston Scientific to eliminate 1,400 jobs in second round since last year
29 July 2011
EU to stop confiscating Indian generic drugs under new deal
29 July 2011
Valeant Pharmaceuticals eyes Swedish specialty drug maker Meda
27 July 2011
Dr. Reddy’s acquires prescription business of JB Chemicals & Pharmaceuticals in Russia & other CIS markets
22 July 2011
Bristol-Myers Squibb to acquire Amira Pharma in a $475 million deal
22 July 2011
Roche to acquire cervical cancer detection firm MTM Laboratories
19 July 2011
Lupin promoters to sell domestic operations: unconfirmed reports
18 July 2011
Glenmark Pharma gets US FDA Final Approval For Nizatidine Capsules
18 July 2011
J&J's Jansen to sell Ortho Dermatologics to Valeant for $345 mn
16 July 2011
HCL, Eli Lilly open Co-Innovation Lab in Singapore
14 July 2011
UK acitivists cry foul as animal experiments rise
14 July 2011
Consortium led by PE firm Apax to buy Kinetic Concepts for $4.98 bn
13 July 2011
Gilead Sciences, Inc in pact with four Indian pharma firms for 3 anti-HIV drugs
12 July 2011
Orchid shuts Alathur plant on pollution concerns
12 July 2011
Sanofi to sell skincare business to Canada's Valeant Pharmaceuticals for $425 mn
11 July 2011
Medtronic to buy two heart-valve device makers in deals worth $645 million
08 July 2011
Pfizer plans to sell animal health and nutrition businesses
07 July 2011
EU regulator approves Eli Lilly’s acquisition of J&J’s animal health unit
07 July 2011
Cadila plant gets FDA warning before it begins production
07 July 2011
US FDA slaps ban on Dr Reddy’s Mexico products
07 July 2011
Inter-ministerial group suggests cut in pharma FDI cap to 49%
06 July 2011
Novartis to file breast cancer combination drug Afinitor
05 July 2011
Wockhardt receives tentative US FDA approval for generic version of Patanol ophthalmic solution
01 July 2011
Strides gets European regulatory nod for oral dosage cancer facility
01 July 2011
GSK to pay $40.75 mn to 37 US states to settle sub-standard manufacturing lawsuit
24 June 2011
AstraZeneca close to selling dental implants unit to Dentsply for $1.8 billion: report
21 June 2011
Wockhardt launches three new products in the United States
21 June 2011
US FDA approves Strides Arcolab's levofloxacin injection
21 June 2011
Russia, China precede India for AstraZeneca's expansion plans
18 June 2011
Zydus Cadila arm to acquire US specialty pharma firm Nesher
17 June 2011
Dr Reddy's chemicals plant in Mexico receives USFDA warning
15 June 2011
Varaprasad Reddy appointed chairman of Shantha Biotechnics, Harish Iyer is CEO
13 June 2011
Novo Nordisk to pay $25 million to settle US probe
13 June 2011
Aurobindo receives USFDA approval for Alprazolam extended-release tablets
08 June 2011
AstraZeneca to pay $250,000 to 124 women for sex discrimination
07 June 2011
Stryker to buy French extremities device company Memometal for $162 million
07 June 2011
Mylan to rename Matrix Lab as 'Mylan'
27 May 2011
Valeant Pharmaceuticals to acquire Lithuania’s AB Sanitas for $443 million
24 May 2011
AstraZeneca, Daiichi Sankyo to promote Amgen's new bone cancer drug
24 May 2011
J&J to buy J B Chemicals’ Russian OTC drugs for $260 million
24 May 2011
Japan's Takeda to acquire Swiss drugmaker Nycomed for $13.6 billion
19 May 2011
Shire to acquire regenerative medicine firm Advanced BioHealing for $750 mn
19 May 2011
Glenmark sells new drug licence to Sanofi for $50 mn
17 May 2011
Japan's Takeda Pharma in $12 billion to buy Swiss rival Nycomed: report
12 May 2011
Alkermes to buy Elan Drug Technologies for $960 million
09 May 2011
Sanofi-Aventis shortens name to Sanofi
07 May 2011
Taro Pharma challenges Suven's ANDA in US court
06 May 2011
Piramal Healthcare to foray into financial services
06 May 2011
Cipla posts lower Q4 net profit of Rs214 crore
06 May 2011
Ranbaxy in settlement talks with USFDA: Reports
05 May 2011
Teva trumps Valeant with a $6.8-bn deal to acquire Cephalon
02 May 2011
Strides oncology facility gets US FDA approval
02 May 2011
Biocon to divest stake in Germany's AxiCorp
28 April 2011
J&J to buy Swiss medical devices maker Synthes for $21.3 billion
27 April 2011
Lupin signs agreement with Abott Laboratories and others for Fenofibrate
27 April 2011
Wockhardt receives US FDA approval for generic Alzheimer's drug
25 April 2011
Sun to co market Merck's Diabetes drugs in India
25 April 2011
Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US
23 April 2011
Wockhardt's generic version of Pfizer's Effexor XR capsules gets US FDA approval
19 April 2011
UK government sues Reckitt Benckiser for £90 mn
18 April 2011
J&J may buy Synthes in $20-bn deal
16 April 2011
Dr. Reddy’s launch generic Fexofenadine HCl antihistamine tablets
14 April 2011
GlaxoSmithKline loses appeal in Rs71.21-crore Drug Price Equalisation Account demand
13 April 2011
Government mulls restictions on unrestricted use of antibiotics
13 April 2011
GW Pharma, Novartis sign deal to market cannabis derivative
12 April 2011
Merck, Sun Pharma in generics JV
11 April 2011
Sinclair Pharma and IS Pharma agree to terms of a £130 million merger
08 April 2011
Indian drug-maker stops sales of 'lethal injection' drug to US
08 April 2011
New drug resistant bugs worry health experts
08 April 2011
CCEA clears Reckitt Benckiser's Rs3,300-cr Paras Pharma acquisition
29 March 2011
AstraZeneca saves over $1 billion in tax dispute settlement
28 March 2011
Quest Diagnostics to acquire Celera Corp for $671 million
19 March 2011
Teva to issue $750 million of bonds at Libor +0.50 per cent
17 March 2011
Regulator hikes prices of domestic insulin, TB drugs
17 March 2011
Eli Lilly to acquire Johnson & Johnson’s animal health unit
15 March 2011
Mount Kellet, others to buy 35 per cent stake in MedPlus
14 March 2011
HC nod for winding up Wockhardt; company to appeal
12 March 2011
Merck hopes to be among top-five drugmakers in India
11 March 2011
Licences for 11 drug formulations withdrawn
09 March 2011
Dr Reddy’s targets $1 bn revenue from generics
07 March 2011
Strides gets US FDA nod to market `Vancomycin' from new facility
04 March 2011
Panacea Biotec in marketing deal with Uruguay's Laboratorios Clausen
03 March 2011
Daiichi Sankyo acquires US cancer drug firm Plexxikon
02 March 2011
Forest Laboratories to acquire Clinical Data for $1.2 billion
23 February 2011
Japanese pharma firm KHK to buy Scotland’s ProStrakan for £292 million
22 February 2011
Boston Scientific introduces new stent systems in India
18 February 2011
Glenmark Pharma files application of human trial in Netherlands for GRC 17536 molecule
17 February 2011
Sanofi-Aventis seals Genzyme deal with $20.1-bn takeover offer
17 February 2011
Mylan gains 180-day marketing exclusivity on Pfizer's Vfend generics
16 February 2011
Lincoln Pharmaceuticals launches long-acting paracetamol
08 February 2011
US court lifts stay on Dr Reddy’s generic allergy drug
01 February 2011
Ranbaxy, Russian region sign MoU on healthcare cooperation
31 January 2011
Export of pharmaceuticals from India to be under trace and track surveillance system
28 January 2011
Novartis to acquire cancer diagnostics company Genoptix for $470 million
25 January 2011
Amgen to acquire BioVex Group Inc for up to $1 billion
25 January 2011
Wockhardt launches generic version of ulcer drug `Protonix' in US
21 January 2011
Generic drugmaker Perrigo to buy Paddock Lab assets for $540 mn
20 January 2011
Boston Scientific to acquire device maker Atritech in a $375 million deal
20 January 2011
Amrutanjan to form JV with Austin Chemical of US
19 January 2011
GlaxoSmithKline to take $3.4-bn legal charge for diabetes drug Avandia
18 January 2011
Lincoln Pharma wins patent for nasal spray to treat vomiting
17 January 2011
Johnson & Johnson mulls fresh assault on Smith & Nephew: report
17 January 2011
Expert calls for war against deadly drug-resistant malaria
15 January 2011
Sinopharm to acquire 80-% stake in Aurobindo's China subsidiary
11 January 2011
Sanofi-Aventis, Genzyme in talks to structure $80 per share deal
08 January 2011
J&J’s McNeil unit sells St Joseph's aspirin brand to Ilex Consumer Products
08 January 2011
Pfizer inks $208 million anti-cancer technology deal with Seattle Genetics
07 January 2011
Merck and Ranbaxy end drug development pact
06 January 2011
Dr Reddy’s set to face Pfizer in court over patent suit
06 January 2011
Lupin in pact to supply TB drug to Brazil
05 January 2011
Pfizer moves court against Dr Reddy's launch of atorvastatin in US market
04 January 2011
Gernmany’s Fresenius Medical to buy Euromedic’s dialysis unit for $648.5 million
04 January 2011
India rejects HIV drug patent application by Abbott Laboratories
03 January 2011
Elder's Patalganga plant gets accreditation from Japan's health ministry.
03 January 2011
CVS Caremark to buy Universal American's Medicare drug business for $1.25 bn
03 January 2011
Pfizer Animal Health to acquire veterinary diagnostics firm Synbiotics Corp
30 December 2010
Strides Arcolab, Akorn to sell US JV products portfolio to Pfizer for $63.2 million
30 December 2010
Surya Pharma acquires US-based OTC analgesic brand ActivOn in $22 million deal
28 December 2010
Transgene to start large-scale trials of new AIDS drug
27 December 2010
Strides Arcolab seeks to hike stake in Pharmahealth
24 December 2010
LyondellBasell sells flavors and fragrances business to Pinova Holdings for $150 million
23 December 2010
Two killed in gas leak at Dr Reddy’s Laboratories in Hyderabad
22 December 2010
Supercomputing research opens doors for drug discovery
22 December 2010
Novartis plans $500 million investment in Russia
21 December 2010
Ranbaxy arm in $134-million AIDS drug supply deal with South African government
20 December 2010
Sharon Bio-Medicine to set up new plant at Sangli in Maharashtra
16 December 2010
GlaxoSmithKline acquires rights to Parkinson’s drug from Impax
16 December 2010
Galderma Pharma launches $970-million bid for cosmetic treatment firm Q-Med
14 December 2010
Sanofi-Aventis extends Genzyme offer, terms unchanged
13 December 2010
Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale
13 December 2010
WikiLeaks: Pfizer derailed investigations over clandestine drug trials in Nigeria
11 December 2010
J&J's McNeil unit recalls over 13 million packets of Rolaids
10 December 2010
Strides acquires controlling stake in Inbiopro in Rs65-crore deal
09 December 2010
Cephalon signs world's biggest stem cell deal with Australia’s Mesoblast
09 December 2010
Johnson & Johnson launches $2.32-bn bid for Dutch biotech firm Crucell NV
08 December 2010
India to retain generics production right under India-EU trade pact
08 December 2010
US medical insurer Aetna to buy Medicity for about $500 million
08 December 2010
Glaxo to buy China's specialist drugmaker MeiRui Pharma for $70 million
08 December 2010
China's Bright Food in talks to buy US vitamin retailer GNC Holdings
07 December 2010
Merck to buy diabetes drug developer SmartCells in a $500 million-plus deal
03 December 2010
Baxter to licence Vero cell-based influenza vaccine technology to Takeda
03 December 2010
GlaxoSmithKline plans to acquire China’s Nanjing MeiRui Pharma
02 December 2010
SC rejects Bayer plea against generic Cipla drug
02 December 2010
Axcan Holdings to buy specialty pharmaceutical firm Eurand for $583 million
02 December 2010
GSK plans to invest £500 million in new projects in UK
01 December 2010
Cardinal Health acquires Chinese drug distributor for $470 million
01 December 2010
US FDA grants tentative approval for Sun's generic Aricept
30 November 2010
Indo-EU deal on drug seizures, FTA likely soon
30 November 2010
Strides Arcolab rebrands specialities business as Agila Specialties
25 November 2010
Solvay Pharma to merge with Abbott India in a 3:2 share swap
25 November 2010
Indian scientists tap bioactive compounds from marine life to develop drugs
24 November 2010
Medtronic to buy hypertension treatment firm Ardian for $800 million
23 November 2010
J&J recalls Benadryl, Motrin
23 November 2010
Claris Lifesciences Rs300 crore IPO set at Rs278-293 a share
22 November 2010
Boston Scientific acquires Sadra Medical for $386 mn
20 November 2010
UK’s specialty pharma firm BTG to acquire Biocompatibles for £177.2 million
19 November 2010
US drug distributor Cardinal Health to buy rival Kinray for $1.3 billion
18 November 2010
Genzyme to sell diagnostics business to Japan’s Sekisui Chemical for $265 million
18 November 2010
Roche to axe 4,800 jobs in $2.1-b restructuring
17 November 2010
Merck aims for top slots in seven emerging markets
15 November 2010
GlaxoSmithKline expands research collaboration with Brazil's Fiocruz
13 November 2010
Suven Life to unveil new drug candidates at US neuroscience meet
12 November 2010
Ranbaxy registers 168 per cent leap in end-Sept profit
12 November 2010
Arthritis drugs could help prevent memory loss after surgery, study suggests
09 November 2010
Eli Lilly's $800-mn Avid deal boosts diagnostic capabilities
09 November 2010
HCL Technologies enters clinical research market in Australia with Novotech deal
08 November 2010
US drug distributor McKesson to acquiire US Oncology in $2.16 billion deal
02 November 2010
World's first mechanical LVAD transplant performed
02 November 2010
Drug controller brings in new rules to curb antibiotics abuse
30 October 2010
Merck KGaA sells women’s health business to Teva for €285 million
30 October 2010
Researchers moot proton therapy as future cancer treatment
30 October 2010
Biocon to invest $161 million in Malaysian biotech firm
28 October 2010
New vaccine holds promise of polio-free future
27 October 2010
GlaxoSmithKline to pay $750 mn to settle US adulterated drugs lawsuit
27 October 2010
Strides' generic oseltamivir receives WHO prequalification for treatment of H1N1
26 October 2010
Dr Reddy's expands sales in Russia & CIS through licensing deals
25 October 2010
Lancet's malarial estimation methodology suspect says WHO
23 October 2010
Genzyme counters Sanofi’s hostile takeover with 2011 earning projections
23 October 2010
Malaria kills 2 lakh in India every year: Lancet report
22 October 2010
Pfizer buys 40-% stake in Brazilian generics firm Teuto for $240 million
20 October 2010
Cipla launches first generic pirfenidone in India
20 October 2010
No standard for placebos in drug trials
19 October 2010
Pfizer, Biocon enter into deal for biosimilar insulin
19 October 2010
Hyderabad research firm announces India’s first cell-cultured H1N1 swine flu vaccine
18 October 2010
Pfizer to buy pain drug company King Pharma for $3.6 billion
12 October 2010
Top global pharma players in fray for Paras
12 October 2010
ImmunoGen to collaborate with Novartis on novel cancer treatment
12 October 2010
Takeda in schizophrenia research pact with Envoy Therapeutics
09 October 2010
India, EU resolve dispute over generic drug seizures
08 October 2010
Scientists shed light on how serotonin works
06 October 2010
Cheek swab may detect lung cancer
06 October 2010
Fresenius Kabi recalls drug made by Indian arm for US sale
04 October 2010
Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid
04 October 2010
Indian scientist develops inexpensive method to isolate anti-cancer agent
04 October 2010
Bangalore-based Strand Life Sciences establishes subsidiary in the US
04 October 2010
Jubilant Life Sciences commences tender offer for Cadista Holdings Inc
01 October 2010
Brain chemical finding could open door to new schizophrenia drugs
01 October 2010
Sun Pharma receives tentative USFDA approval for generic Crestor
30 September 2010
Endo Pharmaceuticals to buy generic drug maker Qualitest for $1.2 billion
28 September 2010
GSK's diabetic drug still on sale in India as regulators dither
28 September 2010
Sun Pharma board approves stock split into Re1 shares
24 September 2010
Regulators in EU, US "kill" Glaxo’s diabetes drug Avandia
24 September 2010
Google sues rogue online pharmacies
23 September 2010
Abbott recalls 5 million infant formulas over beetle larvae contamination
23 September 2010
GSK sues Roche over Genentech's cancer drug patent infringement
23 September 2010
Sun acquires controlling stake in Taro, Shanghvi is chairman
22 September 2010
Piramal starts phase-II trials for type-2 diabetes drug
22 September 2010
Suven Life Sciences wins US patents for NCEs
21 September 2010
Boston Scientific to buy Asthmatx for $193.5 million
21 September 2010
Johnson & Johnson in talks to buy Crucell for $2.3 billion
17 September 2010
Elder Pharmaceuticals to buy UK’s NeutraHealth for Rs70.60 crore
17 September 2010
Forest Labs to pay more than $313 million for selling unapproved drugs
17 September 2010
Pharma MNCs focus on branded generics in India to drive growth
14 September 2010
Daiichi Sankyo gets approval for influenza drugh Ianivir
13 September 2010
Genzyme to sell genetic testing business to LabCorp for $925 million
13 September 2010
3M to buy patient warming products maker Arizant for $810 million
11 September 2010
Abbott to keep Piramal business separate after acquisition
11 September 2010
With Paras Pharma keen to sell, Emami ready to buy
09 September 2010
Sanofi Aventis reportedly raises offer to $71 per share
09 September 2010
Israel Supreme Court lifts injunction on Sun's acquisition of Taro
08 September 2010
Bristol-Myers Squibb offers 84-% premium to buy ZymoGenetics for $885 million
08 September 2010
UK regulator moots withdrawing GSK’s Avandia drug from UK market
06 September 2010
Novartis aqnnounces novel antimalarial drug
06 September 2010
GSK investigates Pandermix link to chronic sleep disorder
04 September 2010
Orexigen, Takeda in $1-billion deal for obesity drug
03 September 2010
Vitamin D found to influence over 200 genes, highlighting links to disease
02 September 2010
Allergan to pay $600 million to settle US probe on anti-wrinkle treatment drug
02 September 2010
Pfizer to acquire FoldRx Pharmaceuticalsing
01 September 2010
USFDA approves Sun's generic version of Lilly's Strattera
01 September 2010
Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer
31 August 2010
Sanofi-Aventis reveals $18.5-billion offer for Genzyme
30 August 2010
J&J unit DePuy issues global recall of 93,000 hip replacement systems
27 August 2010
Cipla to acquire formulations maker Meditab for Rs133.35 crore
25 August 2010
Roche bets $1.1 billion on Aileron Therapeutics stapled peptide
25 August 2010
Medical isotopes shortage likely to push up medical scan costs
25 August 2010
Industry ministry suggests mandatory third party licensing of patented drugs
24 August 2010
Roche to buy cancer diagnostic firm BioImagene Inc for $100 million
24 August 2010
Aurobindo Pharma receives USFDA approvals for Ampicillin for Injection
23 August 2010
Quark Pharmaceuticals inks $680 million drug licensing deal with Novartis
19 August 2010
Medtronic to buy bone graft company Osteotech for $123 million
18 August 2010
RPG Life Sciences enters cardio-vascular segment with introduction of Impulse
17 August 2010
Aspen Pharma’s A$900-million lifeline resucitates Sigma
16 August 2010
Gufic Biosciences wins trademark infringement case against American cosmetic major, Estee Lauder
12 August 2010
US FDA approves Glenmark's corticosteroid
10 August 2010
AstraZeneca to pay $198 million to settle 17,500 Seroquel lawsuits
09 August 2010
Glenmark enters into a settlement and license agreement with Sepracor Inc
09 August 2010
Societies to govern six AIIMS-like institutions
09 August 2010
Anxiety drug found to be effective in substance abuse treatment
07 August 2010
India foils Chinese firm’s bid to patent pudina, kalamegha for flu medicine
07 August 2010
UK’s Shire to buy Belgium's GI drug specialist Movetis for €428 million
04 August 2010
Genzyme begins takeover talks with Sanofi-Aventis
03 August 2010
DBT, UK's Wellcome Trust in £45-million joint health research programme
31 July 2010
Conatus Pharmaceuticals buys Pfizer's Idun subsidiary
31 July 2010
Charles River, WuXi mutually terminate $1.6-billion merger
30 July 2010
Capgemini acquires Skvader Systems AB
30 July 2010
Centaur Pharmaceuticals in-licenses Herpes drug Sorivudine from aRigen Pharmaceuticals Japan
30 July 2010
US court favours Sun Pharma over Eli Lilly’s cancer drug patent on
29 July 2010
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
GlaxoSmithKline net sales up 9 per cent
26 July 2010
Court orders Cadila to pay Rs50,000 in costs to Diat Foods in `Sugarfree' case
24 July 2010
Sanofi-Aventis targets troubled Genzyme Corp for takeover
24 July 2010
Glenmark Generics receives approval from the USFDA for Norethindrone tablets 0.35mg
23 July 2010
Dr Reddys shows steady Q1 performance
23 July 2010
Number of older people with HIV up by 60 per cent in UK
22 July 2010
Reckitt Benckiser to acquire SSL International for €2.54 billion
21 July 2010
Bayer Schering Pharma in research pact with China's largest military hospital
20 July 2010
US FDA warns against steroidal 'dietary supplements' sold on-line
19 July 2010
Taro mulls next move after dismissal of US suit against Sun Pharma
17 July 2010
Sun Pharma announces US FDA approval for generic Flomax
16 July 2010
Aspen takeover plan hits snags as Sigma cuts 2011 guidance
16 July 2010
Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business
15 July 2010
FDA wants GSK to add more health warnings on diabetese drug Avandia
15 July 2010
GlaxoSmithKline: truth is a bitter pill
14 July 2010
Government plans Rs10,000-crore VC fund for drug research
13 July 2010
J&J to buy stroke specialist Micrus Endovascular for $480 million
13 July 2010
Jubilant Organosys to hive off non-pharma biz, amalgamate other units
08 July 2010
Aspen lowers takeover offer for Sigma by 8.3 per cent
08 July 2010
AstraZeneca scrip slumps after buy-back offer
07 July 2010
Sanofi-Aventis gearing to make US acquisition worth $20 billion: report
03 July 2010
Hyderabad-based Aptuit Laurus's parent to acquire GSK's Verona research operations
02 July 2010
Sun Pharma gains 180-day marketing exclusivity for generic Exelon in the US
02 July 2010
Celgene Corporation to buy Abraxis BioScience for $2.9 billion
30 June 2010
Sanofi-Aventis to buy US oncology products firm TargeGen for $560 million
30 June 2010
Abbott to hive off flu vaccine business of Solvay: report
29 June 2010
New inhalable measles vaccine may lead to vaccines for other diseases
29 June 2010
Pharmaceutical companies cut down on R&D, push sales of old drugs: report
28 June 2010
Myanmar destroys illicit drugs worth $76 million
26 June 2010
Former chairman and CEO of Johnson & Johnson Richard B Sellars dies at 94
26 June 2010
Gilead Sciences to buy CGI Pharmaceuticals for up to $120 million
26 June 2010
Sanofi-Aventis signs global licensing pact with Metabolex for Type II diabetes drug
25 June 2010
Merck enters drug distribution pact with South Africa's Adcock Ingram
24 June 2010
Piramal Healthcare to buy BioSyntech's assets for $3.82 billion
22 June 2010
Sun Pharma, Orion settle litigation over generic Stalevo and Comtan
22 June 2010
Sanofi-Aventis signs $750-million microRNA therapeutics deal with Regulus
22 June 2010
Cadila gets nod for Phase I trials of novel oral diabetes drug
21 June 2010
Specialty drugmakers, Biovail and Valeant Pharmaceuticals to merge
21 June 2010
AstraZeneca settles US drug pricing suit for $103 million
19 June 2010
Dabur completes merger of Fem Care Pharma
18 June 2010
Sun Pharma's epilepsy drug granted US FDA approval
17 June 2010
Bayer Schering to develop anti-cancer stem cell therapeutics with OncoMed Pharmaceuticals
17 June 2010
Abbott signs $575 million endometriosis drug deal with Neurocrine
16 June 2010
Suven secures Japanese patents for two Alzheimer drugs
16 June 2010
Cipla to buy stakes in two biotech firms for Rs300 crore
16 June 2010
Cipla profit rises over 39 per cent to Rs1,081.49 crore
15 June 2010
Teva Pharmaceutical hikes stake in diabetes drug developer Andromeda
14 June 2010
US court halts launch of Dr Reddy's anti-allergic drug Allegra D24
14 June 2010
Global pharma giants to pool data to accelerate Alzheimer treatment
12 June 2010
GlaxoSmithKline acquires Argentina’s Laboratorios Phoenix for $253 million
11 June 2010
Sanofi Aventis signs antibody research deal with Vivalis SA
09 June 2010
Grifols to buy Talecris Bio for $3.4 billion
07 June 2010
Hydro power generation at country's largest plant records 25-per cent growth
07 June 2010
Grifols of Spain in talks to acquire Talecris Biotherapeutics for $3 billion
07 June 2010
Ranbaxy recalls nerve pain drug from UK market
04 June 2010
Sanofi-Aventis signs $398-million cancer drug license deal with Ascenta Therapeutics
04 June 2010
Sun rejects Guggenheim's $215 million offer for Taro stake
03 June 2010
Covidien to buy ev3 for $2.6 billion to expand into vascular devices market
01 June 2010
Sanofi-Aventis and Nichi-Iko Pharmaceutical to form generic drug JV
29 May 2010
Central government hospitals to prescribe generic medicines as well
28 May 2010
India's first dental stem cell bank launched
27 May 2010
Sigma Pharmaceuticals reveals mystery bidder is South Africa’s Aspen Pharmacare
25 May 2010
Sun Pharma net profit falls nearly 29 per cent to Rs898 crore
24 May 2010
CBI raids reveal expired drug use at CGHS hospitals
22 May 2010
Fake drug sales on the rise, warn experts at WHO meet
22 May 2010
WHO rapped for mislabelling Indian generics as counterfeits
22 May 2010
Abbott is India's biggest pharma firm after $3.7-bn Piramal deal
21 May 2010
Mystery bidder offers A$707 million for loss making Sigma Pharmaceuticals
21 May 2010
Novartis penalised $250 million for gender bias against women
20 May 2010
Pfizer to close eight plants, shed 6,000 jobs worldwide
18 May 2010
OSI accepts Astellas's $4-billion revised offer
17 May 2010
Dr Reddy's gets US nod for Prograf generic and expects 20 per cent in FY11
15 May 2010
After Cipla, Pfizer firms licensing pact with Strides Arcolab
14 May 2010
Ranbaxy boosts Daiichi Sankyo’s Q1 profits
13 May 2010
India, Brazil launch plaint against EU over drug seizures
13 May 2010
Cadila's H1N1 vaccine approved for launch in India
13 May 2010
Strides Arcolab receives US FDA approval for Bacitracin
12 May 2010
GSK acquires 9.9-per cent stake in S Korea's top phrma firm, Dong-A
12 May 2010
Abbott signs agreement to market 24 Zydus Cadila products
12 May 2010
Ranbaxy posts spectacular profit from last year's loss
11 May 2010
Merck settles Zetia patent suit with Glenmark
11 May 2010
Glenmark's US subsidiary gets US FDA approval for Tarka generic
10 May 2010
Cipla in talks for supply of drugs to Pfizer: Reports
08 May 2010
inVentiv Health to be acquired by Thomas H Lee Partners for $1.1 billion
07 May 2010
Glenmark Generics licenses branded drug to Taro USA
06 May 2010
Endo Pharmaceuticals to acquire HealthTronics for $223 million
06 May 2010
Lupin net profit up 40 per cent in Q4
05 May 2010
Orchid in out-licensing deal with Alvogen for oral non-antibiotic for US sales
05 May 2010
Johnson & Johnson recalls 43 children's drugs
03 May 2010
Indian pharma sector: sound fundamentals despite increasing challenges
03 May 2010
Glenmark in $325-million drug deal with Sanofi-Aventis
03 May 2010
Orchid also settles Namenda patent issues with Forest Labs
29 April 2010
Medtronic to acquire ATS Medical for $370 million
29 April 2010
Glenmark launches Prasugrel for heart patients in India
29 April 2010
GSK Q1 earnings surge on swine flue vaccine
29 April 2010
Wockhardt launches prostate drug Flomax in the US
28 April 2010
AstraZeneca settles Seroquel case with US government for $520 million
28 April 2010
Indo-EU trade deal will hit drug prices: humanitarians
27 April 2010
Charles River to buy China’s WuXi PharmaTech for $1.6 billion
26 April 2010
US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin
24 April 2010
India to move WTO over drug seizures by EU: CNBC-TV 18
20 April 2010
Astellas not to raise offer for OSI despite FDA approving Tarceva
20 April 2010
Hospira to acquire Javelin Pharmaceuticals for $145 million
20 April 2010
Novartis acquires generic respiratory drug maker Oriel Therapeutics
19 April 2010
Trials of imported HPV vaccines end as six girls die
17 April 2010
Boston Scientific to resume defibrillators sales
16 April 2010
Dr Reddy's introduces new 'metered dose inhalers' in India
15 April 2010
Ranbaxy recalls two consignments of drugs from US market
15 April 2010
Glenmark settles malaria drug patent dispute with GlaxoSmithKline
12 April 2010
Sun Pharmaceutical gets tentative US FDA approval for Alzheimer’s treatment
10 April 2010
Sanofi-Aventis in $335-million diabetes drug deal with CureDM
08 April 2010
Glenmark launches two new generics in UK
07 April 2010
Opto Circuits acquires Kokata-based N S Remedies
05 April 2010
MDRNA acquires Cequent Pharma for $46 million
03 April 2010
Sanofi-Aventis settles patent infringement suit with generic drug manufacturers
03 April 2010
Wockhardt deal with Abbott falls through as foreign investors cry foul
03 April 2010
AstraZeneca, Bristol-Myers Squibb in diabetes research alliance
01 April 2010
Dr Reddy’s Lab board approves bonus debentures valued at Rs30/share
01 April 2010
FDA accepts Glenmark’s painkiller oxycodone hydrochloride for review
01 April 2010
GSK, Isis Pharma in RNA therapeutics licencing pact
31 March 2010
Boston Scientific under US FDA scrutiny for defibrillators recall
30 March 2010
Ranbaxy, Dow arm tie up to develop biosimilar protein
29 March 2010
Switzerland’s Lonza in talks to acquire majority stake in drug firm Aptuit Laurus
24 March 2010
Suven granted US patent for drug useful in CNS disorders
23 March 2010
Piramal acquires Cipla's OTC contraceptive brand `i-pill' for Rs95 crore
23 March 2010
Abbott completes acquisition of Starlims Technologies
23 March 2010
UB Group sells Aventis stake for Rs414 crore
23 March 2010
Aurobindo Pharma epilepsy drug gets Canadian approval
22 March 2010
Biocon arm Syngene, Endo Pharma tie up for biological cancer drug
22 March 2010
Lupin’s sleep disorder drug gets USFDA nod
22 March 2010
Panacea Bio wins Rs10 crore government aid for developing swine flu vaccine
22 March 2010
India's pharma exports record CAGR of 21.25 per cent in FY'07-FY'09
20 March 2010
Strides Arcolab acquires SA firm Aspen's stake in two joint ventures
19 March 2010
Further expansion of branded generics, OTC and dermatology portfolio
19 March 2010
Teva to acquire Germany's Ratiopharm for $5 billion
18 March 2010
Glenmark receives FDA approval for Moexipril Hydrochloride tablets
18 March 2010
Sun Pharma gets USFDA approval for generic Prometh syrup
18 March 2010
GVK Biosciences opens new clinical pharmacology unit in Ahmedabad
17 March 2010
Strides Arcolab to delist Aussie subsidiary Ascent Pharmahealth by acquiring publicly held shares
17 March 2010
OSI Pharmaceuticals rejects Astellas $3.5-billion hostile bid
17 March 2010
Boston Scientific suspends sales of seven defibrillators
17 March 2010
Eli Lilly inks $335 million licensing deal with Australia’s Acrux
17 March 2010
Sigma-Aldrich to sell Pfizer's bioactive small molecule compounds
15 March 2010
MCI all set to amend Medical Ethics Regulations
13 March 2010
Sanofi-Aventis concludes Chattem acquisition
13 March 2010
Battelle, IBM, Merck join UPMC’s effort to produce vaccines
12 March 2010
Torrent in AstraZeneca's debut deal to sell branded generics
11 March 2010
FDA grants "orphan drug" status to Bayer's Ciprofloxacin dry powder inhaler for cystic fibrosis
11 March 2010
Abbott receives US FDA approval for new cataract multifocal intraocular lens
11 March 2010
Abbott Laboratories to acquire Facet Biotech for $450 million
10 March 2010
GlaxoSmithKline on the prowl for acquisitions in India
09 March 2010
Eli Lilly’s Elanco takes over Pfizer’s European animal health portfolio
09 March 2010
Strides Arcolab buys back divested Brazillian facility from Aspen for $75 million
05 March 2010
Astellas sues OSI Pharmaceuticals for adopting poison pill tactics
04 March 2010
Pfizer in bid to snap up Germany’s Ratiopharm
04 March 2010
Aurobindo Pharma's antibiotic ANDA gets Canadian approval
03 March 2010
US FDA rejects Ranbaxy's application for generic Flomax
03 March 2010
Transgene Biotek files patents for liver and breast cancer drugs
03 March 2010
Panacea Biotec develops Swine flu vaccine
03 March 2010
Astellas launches $3.5-billion hostile bid for OSI Pharmaceuticals
02 March 2010
Merck KGaA beats Thermo Fisher to acquire Millipore for $7.2 billion
02 March 2010
Aurobindo gets US FDA nod for 50mg dosage of HIV drug `Nevirapine'
26 February 2010
Ranbaxy swings back to profit
25 February 2010
AstraZeneca settles UK tax dispute with £505 million payout
24 February 2010
AstraZeneca India to pay 500 per cent dividend
23 February 2010
Thermo Fisher plans to acquire Millipore for $6 billion: report
23 February 2010
GlaxoSmithKline forced to remove zinc from denture cream products
22 February 2010
Unichem APIs `Meloxicam' and `Zolpidem Tartrate' get European approval
19 February 2010
Biogen assumes full development responsibilities for hemophilia therapy
18 February 2010
US drugstore chain operator Walgreen to acquire rival Duane Reade for $1.08 billion
18 February 2010
Abbott bids for 20 per cent of Solvay India
17 February 2010
New guidelines for doctors open to changes: MCI chief
16 February 2010
GSK Pharma posts Q4 PAT of Rs103.59 crore
16 February 2010
AstraZeneca inks arthritis drug deal with Rigel
16 February 2010
CSL faces the heat as Mayo Clinic joins class action suit
15 February 2010
Alexza Pharmaceuticals collaborates with Biovail for schizophrenia drug
11 February 2010
US FDA approves AstraZeneca's Crestor
09 February 2010
Scientists discover new treatment for chronic pain condition
08 February 2010
Newly engineered enzyme is a powerful staph antibiotic
06 February 2010
US FDA asks Ranbaxy to ensure plant standards compliance: report
05 February 2010
GlaxoSmithKline keeps jobs as 2009 profit jump 12 per cent to £8.73 billion
05 February 2010
Weight training improves cognitive function in seniors
05 February 2010
Rights groups contest human gene patent in US court
04 February 2010
GlaxoSmithKline inks up to $330 million drug deal with Apeiron Biologics
03 February 2010
Boston Scientific to pay J&J $1.73 billion in patent settlement
02 February 2010
Cephalon to acquire Swiss generic firm Mepha for $590 million
01 February 2010
GlaxoSmithKline may follow AstraZeneca in axing jobs: report
01 February 2010
Lupin receives US FDA approval for perindopril erbumine tablets
29 January 2010
Vitamin D can contribute to inflammatory bowel disease
29 January 2010
AstraZeneca reports profit, cuts 8,000 jobs to cut costs
29 January 2010
Enzon stockholders approve sale of specialty pharmaceutical business
28 January 2010
Widely used anti-obesity drug Sibutramine under FDA scanner
25 January 2010
Medtronic to acquire Invatec for $350 million
25 January 2010
Bayer to abandon haemophilia drug trial
25 January 2010
Researchers create new 'smart' nanocapsule delivery system for use in protein therapy
21 January 2010
Dr Reddy’ Labs posts consolidated net loss of Rs522 crore
21 January 2010
Alcon directors deride Novartis offer as grossly inadequate
20 January 2010
Ranbaxy acquires Biovel to enter vaccines business
19 January 2010
Bombay HC rejects plea to block Wockhardt deal with Abbott
18 January 2010
J&J adds several popular brands to Tylenol recall lots
16 January 2010
US justice dept hauls J&J to court for paying kickbacks
16 January 2010
EC probes pharma patent settlements to stall generic launches
13 January 2010
Wockhardt receives US FDA approval for antibacterial Levofloxacin
13 January 2010
LyondellBasell's `Moplen' resin used to replace steel in cleaning equipment
11 January 2010
Ministry stays DCGI ban on Natco's generic cancer drug
11 January 2010
GSK inching closer to deal with Dr Reddy's?
08 January 2010
EU launches probe against Lundbeck for stalling generic drugs
08 January 2010
Orchid receives tentative FDA approval for Alzheimer’s drug Memantine tablet
08 January 2010
AstraZeneca settles another Nexium patent litigation for US sales
07 January 2010
Pfizer to market 40 Strides Arcolab generic drugs in the US
07 January 2010
Wockhardt gets US FDA approval for Alzheimer's drug Memantine
06 January 2010
Dr Reddy’s all-new diabetes drug shows good results
06 January 2010
Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million
04 January 2010
Novartis acquires 52 per cent additional stake in Alcon for $28.1 billion
04 January 2010
Sun fails to dislodge Taro directors at general body
01 January 2010
Ranbaxy sells Chinese JV stake to state-owned firm
29 December 2009
Dr Reddy's to launch new drugs to boost domestic operations
28 December 2009
DCGI asks GSK to withdraw promotional campaign
26 December 2009
Ranbaxy again feels FDA heat – this time over US plant
26 December 2009
Teva-Kowa Pharma to acquire majority stake in Japanese genrics maker Taisho
24 December 2009
Boston Scientific pays $22 million to settle DOJ probe on kickbacks
24 December 2009
AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs
24 December 2009
Novartis acquires Corthera, gets global rights to new heart drug
23 December 2009
Glass Lewis supports Sun in Taro battle
23 December 2009
Lupin settles dispute with Forest Labs over Namenda
22 December 2009
Templeton cold to Taro’s plea for protection against Sun
22 December 2009
Seattle Genetics in antibody development deal with GSK
22 December 2009
Sanofi-aventis to acquire Chattem for $1.9 billion
21 December 2009
Ranbaxy to launch anti-hypertensive drug in six African countries
21 December 2009
Eli Lilly wins drug patent case vs Dr Reddy's in UK
18 December 2009
Sun Pharma advises Taro shareholders against voting at AGM
18 December 2009
India's FY09 pharma exports up 25 per cent at Rs38,433 crore
17 December 2009
J&J to buy ENT device maker Acclarent for $785 million
17 December 2009
Hospira of US buys Orchid’s injectables business
16 December 2009
Abbott to acquire Starlims Technologies for $123 million
15 December 2009
GSK and Intercell to develop innovative needle-free patch-based vaccines
12 December 2009
Taro again warns shareholders to stay away from Sun
12 December 2009
GlaxoSmithkline suspends operations at Andhra unit
11 December 2009
Glaxo targets emerging markets for acquisitions, tie-ups
11 December 2009
Biocon, HCG hospitals team up to fight cervical cancer
10 December 2009
EU raids pharmaceutical companies for anti-competitive business deals
10 December 2009
EKO Diagnostics to provide PET biomarkers to Siemens in Kolkata
09 December 2009
Ranbaxy exits JV with Japan’s Nippon Chemiphar
09 December 2009
Cipla gets notice for overpricing drugs; denies liability
08 December 2009
Celgene to acquire Gloucester Pharmaceuticals for $640 million
08 December 2009
Templeton switches sides; backs Sun on Taro takeover
02 December 2009
Genzyme starts shipments of drugs for two rare disorders
02 December 2009
Bayer Schering Pharma, Micromet to collaborate on developing new cancer antibody
02 December 2009
Pfizer inks $115 million deal with Israel’s Protalix for treatment of Gaucher’s disease
02 December 2009
Jubilant and Eli Lilly extend collaboration for five years
01 December 2009
Wockhardt settles with lender DBS Bank out of court
30 November 2009
Sanofi-Aventis signs drug localisation pact with Russia
28 November 2009
Ranbaxy launches generic herpes drug in US
27 November 2009
Sun Pharma gets FDA nod for selling generic drug
27 November 2009
Novartis gains rights to two oral investigational therapies for life-threatening blood disorders, cancers
25 November 2009
General Atlantic may buy stake in Strides Arcolab
24 November 2009
Merck wins summary judgment in Vioxx lawsuit in Texas
23 November 2009
Merck receives FDA approval for new fertility drug for women
21 November 2009
US FDA clears Boston Scientific's fully covered oesophageal stent
21 November 2009
Bristol-Myers to divest Mead Johnson for $7.69 billion
16 November 2009
Glenmark gets nod to market skin cream in US
16 November 2009
Cipla launches generic drugs for swine flu treatment
14 November 2009
Torrent opens exclusive human insulin unit for Novo Nordisk
14 November 2009
Aurbindo to merge subsidiary Trident Life Sciences Ltd
13 November 2009
Pfizer to slash R&D facilities post Wyeth merger
11 November 2009
Sanofi-Aventis expands Regeneron research deal to $1 billion
11 November 2009
India wins two creative Global Awards for healthcare communcations
11 November 2009
Enzon to sell specialty pharma business
09 November 2009
Dr Reddy's seeks US marketing rights for `Lipitor' generic
07 November 2009
J&J to axe more than 7,000 jobs in restructuring
04 November 2009
Spurious drugs: government announces reward scheme for whistleblowers
03 November 2009
Wockhardt reports Rs54 crore Q3 net loss
31 October 2009
Cadila launches first indigenously prepared TB drug
31 October 2009
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
30 October 2009
Sun Pharma earnings decline less-than-expected, Cipla earnings jump 82 per cent on forex gains
29 October 2009
Ranbaxy posts Rs186.08 crore in Q2 profits
27 October 2009
Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
27 October 2009
Astellas to terminate development of anti-human antibody for RA
26 October 2009
EU watchdog places Biogen’s Tysabri under scanner
24 October 2009
Dr Reddy's July-September net zooms 106 per cent to Rs217 crore
23 October 2009
Pfizer unit fined record $1.3 billion for drug misbranding
19 October 2009
Pfizer completes Wyeth acquisition
16 October 2009
Eli Lilly to hive off Tippecanoe laboratory to Evonik Industries
15 October 2009
Suven Life's Alzheimer's drug candidate granted patents in 9 markets
14 October 2009
Piramal Lifesciences to invest Rs200 crore in drug researh
14 October 2009
Merck KGaA acquires Banagalore bioscience firm
13 October 2009
Novartis enters into $265-million schizophrenia drug deal with Vanda
13 October 2009
Novartis acquires global marketing rights for new drug from Paratek
09 October 2009
FDA advisory committee recommends approval of Pfizer’s Selzentry for HIV
09 October 2009
EU official raid Ranbaxy French unit
08 October 2009
Global pharmaceutical market to exceed $825 billion in 2010, says IMS
08 October 2009
Securities Tribunal asks Daiichi to offer Rs160 per Zenotech share
08 October 2009
GSK receives orders for 440 million doses of H1N1 vaccine
06 October 2009
Ranbaxy to market Daiichi Sankyo products in Mexico
05 October 2009
Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon
01 October 2009
Boston Scientific and Johnson & Johnson settle patent disputes
30 September 2009
Academia Sinica joins Eli Lilly's new TB drug discovery programme
30 September 2009
Israeli drug firm Taro sues Sun Pharma in US
30 September 2009
Wockhardt receives US FDA approval for prostrate drug
29 September 2009
Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies
29 September 2009
Lupin buys US rights for cholesterol drug Antara
29 September 2009
Abbott to acquire Belgian drug company Solvay for $6.6 billion
29 September 2009
Pharma giants worried about India’s generic expertise: Sharma
26 September 2009
Strides Arcolab launches H1N1 drug ‘Starflu’
26 September 2009
US Army claims `modest' success with AIDS vaccine trials in Thailand
24 September 2009
Wockhardt is top Indian pharma patentee; bags government award
24 September 2009
Astellas files suit against Teva for patent infringement in the US
24 September 2009
Venus Remedies outlicenses drug to South Korean firm
23 September 2009
Bayer to supply WHO with drug for African sleeping sickness
23 September 2009
Eli Lilly unveils plans to speed drug development
23 September 2009
Pfizer, Wyeth to sell animal drugs business to Boehringer
23 September 2009
Increasing incomes to boost costly drug sales: FICCI
22 September 2009
Merck, Wellcome Trust tie up to make affordable drugs in India
19 September 2009
Glaxo seeking stake in Dr Reddy’s: report
18 September 2009
Orchid receives USFDA approval for Zaleplon capsules
18 September 2009
Natco Pharma launches H1N1 drug ‘Natflu’
18 September 2009
Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea
17 September 2009
Government opens window for retail sale of H1N1 drug
15 September 2009
Eli Lilly plans 5,500 job cuts to save $1 billion
15 September 2009
Suven Life Sciences secures 2 US patents for new chemicals
14 September 2009
BASF India board okays Ciba India merger
14 September 2009
Dr Reddy's scotches stake sale rumours
11 September 2009
Six new national pharmaceutical institutes to be set up on PPP model
11 September 2009
Biocon in hybrid drug development pact with Amylin
11 September 2009
Hyderabad’s Suven gets first payoff from Eli Lilly tie-up
08 September 2009
Sigma acquires Bristol-Myers Sqibb’s brands
07 September 2009
Aurobindo Pharma receives USFDA, Swissmedic approval for drugs
07 September 2009
States lose power to certify drug exports
07 September 2009
Ranbaxy launches authorised generic version of Validus's Rocaltrol
03 September 2009
GSK to test swine flu vaccine in India at selected sites
03 September 2009
LEO Pharma to Acquire Peplin for $287.5 million
03 September 2009
Bayer acquires two prescription dermatology product lines from SkinMedica in the US
03 September 2009
Dainippon Sumitomo close to buy US drug maker Sepracor
03 September 2009
Pfizer agrees to pay $2.3 billion to settle illegal marketing case
03 September 2009
Vivimed Labs completes buyback of FCCBs totalling $12.5 million
02 September 2009
Roche buys Lonza’s Singapore unit for $360 million
02 September 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
Facet Biotech, Trubion in $196 million cancer drug deal
31 August 2009
Novartis moves Supreme Court on Glivec patent
29 August 2009
SC refuses to hear Roche's patent plea against Cipla
28 August 2009
Capital subsidy scheme for SSI pharma units to cover 179 items
27 August 2009
Cipla to raise Rs1500 crore; eyes Chinese partner
27 August 2009
Suven Life in talks with global pharma firms for its Alzheimer drug
25 August 2009
Ranbaxy's peptic ulcer drug cleared for US launch
25 August 2009
Warner Chilcott acquires P&G's global pharmaceuticals business for $3.1 billion
25 August 2009
Clinical trials for Valeant's shingles pain drug show no conclusive benefit
24 August 2009
Wockhardt completes sale of veterinary business to Vétoquinol
20 August 2009
Delhi High Court allows Cipla to sell generic cancer drug
19 August 2009
Panacea Biotec wins $222.37 million UNICEF contract for EasyFive vaccine
19 August 2009
Glenmark, Forest drug trial for COPD fails
19 August 2009
Glenmark faces GSK patent challenge in US over malaria drug
18 August 2009
Sun Pharma wins Gemzar patent motion against Eli Lilly in US court
18 August 2009
Aurobindo Pharma to acquire Trident Life Sciences
17 August 2009
Swine flu bolsters Indian pharma stocks
11 August 2009
Delhi HC rejects Reckitt Benkiser's claims against Wyeth
11 August 2009
India to crack down on fake Chinese drugs
11 August 2009
Merck, Schering-Plough shareholders approve $41-billion deal
10 August 2009
Pfizer, Mylan lower HIV drug prices for drug-resistant patients
08 August 2009
Aurobindo wins FDA nod for generic drug
08 August 2009
Dr Reddy's Lab launches skin patch pain reliever in India
06 August 2009
FDA bans Teva Animal Health’s veterinary drugs
03 August 2009
Sun Pharma settles Ethyol dispute with MedImmune
03 August 2009
Pfizer settles Trovan cases; pays $75 million to Nigerian state
31 July 2009
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
30 July 2009
Mylan says FDA approves its drug production
29 July 2009
Wockhardt sells its nutrition businesses to Abbott for $130 million
28 July 2009
Chinese-made fake Indian drugs hurt industry's image in Africa
28 July 2009
Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore
27 July 2009
Azad hints at nexus between private-public vaccine units
25 July 2009
Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13
23 July 2009
Bristol-Myers to acquire biotechnology company Medarex for $2.4 billion
23 July 2009
Merck’s Q2 profit falls, but beats expectations
22 July 2009
Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore
21 July 2009
EC approves Pfizer's $68-billion acquisition of Wyeth
18 July 2009
Daiichi's 'low' bid for Zenotech faces new hurdles
16 July 2009
Merck, Schering-Plough settle Vyotorin dispute with states
16 July 2009
No decision yet on bringing essential drug under price control
11 July 2009
Streptokinase, A Life Saving Drug, Developed in collaboration with CSIR launched for Indian Market
11 July 2009
Cadila Pharmaceuticals launches joint venture with Novavax in India
10 July 2009
Sun Pharma to license key escitalopram patent applications to Lundbeck
10 July 2009
NPPA asks Cipla to pay for overcharging on drugs
10 July 2009
Ranbaxy's US subsidiary recalls anti-acne drug from US market
10 July 2009
Researchers claim phenoxodiol kills rapidly proliferating T-cells
09 July 2009
After US FDA raid, Sun Pharma’s US subsidiary slashes half its workforce
07 July 2009
Pharma's biggest boost comes from removal of fringe benefit tax
07 July 2009
Novartis' patent aplication for cancer drug Glivec rejected
07 July 2009
J&J to invest $1.5 billion in Elan’s Alzheimer’s drugs
03 July 2009
Lupin announces acquisition of worldwide rights for its nasal spray, AllerNaze
01 July 2009
J&J awarded $1.67 billion in patent suit against Abbott Laboratories
30 June 2009
Cash-strapped Wockhardt sells veterinary arm to France’s Vetoquinol
29 June 2009
Sun Pharma puts up brave face after FDA crackdown
27 June 2009
Sanofi’s diabetes drug may increase cancer risk: European study
27 June 2009
US FDA seizes drugs from Sun Pharma subsidiary Caraco
26 June 2009
Genzyme confident of restarting virus-hit Allston plant by August
26 June 2009
Sandoz receives approval for first-ever Japanese biosimilar
25 June 2009
Pfizer sweetens bid for India arm to Rs830 per share
25 June 2009
GSK signs drug pact with Chroma Therapeutics
24 June 2009
FDA calls for immediate stop to use of Zicam Cold Remedy and associated products
19 June 2009
Clinical trials using humans must now be registered
18 June 2009
Watson Pharmaceuticals to acquire Arrow Group for $1.75 billion
17 June 2009
Genzyme Corp shuts key facility to clean plant contamination
17 June 2009
Glaxo ties up with Dr Reddy's for emerging markets
15 June 2009
Eli Lilly made false claims of Zyprexa effectiveness
15 June 2009
China pushes fake "Indian" drugs in Africa
10 June 2009
GSK in new venture pact with Shenzhen Neptunus to make influenza vaccines in China
09 June 2009
Zydus Cadilla files application for anti-diabetes drug
04 June 2009
Adcock Ingram drops plans to acquire Cipla Medpro SA
02 June 2009
Bayer HealthCare and Genzyme finalise strategic alliance agreement
02 June 2009
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan
01 June 2009
Bristol-Myers Squibb may acquire minority stake in Irish biotech firm
01 June 2009
Ranbaxy holds breath as FDA scrutinises corrective action plan
30 May 2009
Sanofi-Aventis inks cancer drug research deal with Exelixis
29 May 2009
Novartis ups offer price for Indian arm to Rs450 per share
28 May 2009
Skyepharma's new asthma drug `Flutiform, accepted for FDA review
27 May 2009
Ranbaxy seeks to downplay Malvinder exit
25 May 2009
Malvinder Singh relinquishes charge of Ranbaxy; Daiichi takes over
25 May 2009
J&J plans buyout of Cougar Biotech for $1 billion
23 May 2009
Ranbaxy acquires rights for Ochoa Labs’ skincare products
22 May 2009
Dr Reddy’s reorganises drug discovery operation; receives approval for three INDs
21 May 2009
Pfizer to expand presence in generic drugs marketing
21 May 2009
Merck plans buy-back of 35 per cent equity at Rs435 a share
20 May 2009
Biovail buys Cambridge Lab’s Huntington's disease drug
19 May 2009
Piramal Life Sciences gets regulatory nod for studies on cancer molecule
13 May 2009
Lupin reaches settlement with Wyeth on patented drug
13 May 2009
India gears up to mass-produce H1N1 flu vaccine
13 May 2009
Biocon's Kiran Mazumdar Shaw to receive Nikkei Asia Prize
11 May 2009
Aurobindo gets Australian nod for cholesterol pills
11 May 2009
Wockhardt to hive off animal health care business
07 May 2009
Ranbaxy's anti-malaria molecule enters Phase III clinical trial
06 May 2009
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
Jubilant signs research deal with Anglo-Swedish firm AstraZeneca
06 May 2009
Ranbaxy recalls Nitrofurantoin capsules in the US
02 May 2009
Wockhardt settles patent row with Orion Corporation
29 April 2009
Glenmark gets USFDA approval for cholesterol-lowering agent Ezetimibe
28 April 2009
Wockhardt reports Rs139 crore net loss in Q4'08
25 April 2009
WHO worried over drug-resistant malaria strain
25 April 2009
Cipla feels FDA heat: nine ‘deviations’ found
20 April 2009
GSK close to acquiring Stiefel Lab for $3 billion
20 April 2009
GSK, Pfizer to merge HIV businesses into a new company
17 April 2009
Natco, Dr Reddy’s tie up for cancer generics
16 April 2009
Proxy war heats up as Icahn calls for Amylin chairman’s resignation
16 April 2009
Sanofi to buy US cancer drug firm for about $500 million
15 April 2009
Pharmacy benefits manager Express Scripts buys peer NextRx for $4.68 billion
14 April 2009
Indian drug pricing regulator to launch national media campaign
14 April 2009
Glenmark’s molecule for pain disorders clear Phase I trials in Europe
13 April 2009
Pfizer seeks to increase stake in Indian arm
13 April 2009
Scottish and Chinese centres join hands for stem cell research
13 April 2009
FDA nod for Stride Arcolabs’ AIDS drug combo
11 April 2009
Lupin, Natco team up for generic launch of Shire's `Fosrenol'
09 April 2009
Genentech pulls drug from US market after health scare
09 April 2009
PPDI sells Piedmont R&D center; acquires Magen BioSciences
04 April 2009
Piramal Healthcare to shut down UK unit
02 April 2009
Glenmark to withdraw painkiller from US market
02 April 2009
Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod
01 April 2009
Wockhardt CMD Khorakiwala quits; Fortis takeover likely
01 April 2009
Cadilla’s ‘magic bullet’ polycap clears first big test
01 April 2009
Bayer sells 3 cancer drugs to Genzyme for $650 million
01 April 2009
Wockhardt’s debt hard pill to swallow for investors
01 April 2009
Ranbaxy to launch Daiichi's hypertension drug in India
31 March 2009
Zydus Cadila, Eli Lily tie up for cardiovascular drug research
30 March 2009
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
GSK eyes push into emerging markets through Asken buy
28 March 2009
After Matrix who will be delisted next?
28 March 2009
Novartis's open offer for Indian arm to begin on 14 May
27 March 2009
Strides Arcolab gets USFDA approval for its Bangalore facility
27 March 2009
US pharmaceutical company Hospira to cut 10 per cent of workforce
25 March 2009
Novartis makes open offer for 39 per cent in Indian arm
25 March 2009
Bristol-Myers, Syngene open new R&D facility
24 March 2009
UK, Australia okay drugs from Ranbaxy plant
24 March 2009
Hikal plans to take over its own pharma co
23 March 2009
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
Dr Reddy’s pulling out of small global markets
21 March 2009
Dr Reddy’s sales in Russia and CIS top $150 million
19 March 2009
Aspirin can help prevent heart attacks, strokes
19 March 2009
Pfizer raises $13.5-billion debt to part finance Wyeth acquisition
18 March 2009
Astellas withdraws from race to acquire CV Therapeutics
16 March 2009
Cholesterol-lowering statins reduce severe asthma attacks and hospitalisations
16 March 2009
Matrix gets tentative US FDA nod for HIV inhibitor drug
13 March 2009
US court clears Dr Reddy’s in Omeprazole Mg OTC litigation
13 March 2009
Gilead Sciences to acquire CV Therapeutics for $1.4 billion
13 March 2009
Pharma majors under merger pressure after Merck-Schering deal
12 March 2009
Roche calls Genentech’s $112 a share demand unreasonable, may reach agreement on $95 a share
10 March 2009
Biocon arm Syngene in R&D pact with DuPont Crop Protection
09 March 2009
Merck to acquire Schering- Plough for $41 billion
09 March 2009
Pfizer sells insulin assets to Anti-diabetes drugmaker MannKind for $33 million
09 March 2009
Takeda shares plummet as FDA delays new drug
09 March 2009
Ranbaxy's cardio drug `Ramipril' gets US FDA approval
09 March 2009
Medicated patch can cause burns during MRI, warns FDA
09 March 2009
Roche raises Genentech offer from $86.50 to $93 a share
07 March 2009
New bill seeks to bring plants exporting drugs to US under FDA inspection
05 March 2009
Pfizer ties up with Aurobindo for generic drugs
04 March 2009
Pfizer acquires rights to several generics from Aurobindo
03 March 2009
Beckman to acquire Olympus unit for $800 million
02 March 2009
UK watchdog cautions parents giving cold and cough medicines to children
02 March 2009
Cephalon opens bid for Aussie bio-technology firm Arana
28 February 2009
Japan’s No.2 drugmaker Astellas makes $1-billion hostile bid for US firm CV Therapeutics
28 February 2009
US drug firm Cephalon makes $329 million offer for Australia's Arana
27 February 2009
Daiichi, Ranbaxy form team to face FDA charges
27 February 2009
Wockhardt to launch ulcer drug Ranitidine in the US
26 February 2009
Ranbaxy plant in India falsified data: US FDA
25 February 2009
Biogen in talks to acquire Acorda for multiple sclerosis pill
25 February 2009
Genentech tells shareholders to reject Roche bid
24 February 2009
Medtronic buys CoreValue, Ventor Technologies for $1.03 billion
24 February 2009
SC notice to Ramadoss on closure of public sector vaccine units
21 February 2009
Sale of Genentech skin drug `Raptiva' suspended after 3 deaths
20 February 2009
US, China in race for top slot in global wind industry
17 February 2009
Dutch minister promises a re-look at drug seizures on patent issues
11 February 2009
PPF ends opposition to Zentiva sale; Sanofi takeover likely
11 February 2009
Indian medicines made safer from patent piracy
10 February 2009
Medical world abuzz about cancer-killing CyberKnife
10 February 2009
Danish drugmaker Lundbeck to acquire Ovation of US for $900 million
09 February 2009
Piramal Healthcare denies reports of Glaxo, Sanofi bid
07 February 2009
Bird flu fears in China prompt extensive vaccination, closure of Hong Kong sanctuary
07 February 2009
Carl Icahn attempts to get nominees on Biogen board after blockbuster drug drags
07 February 2009
Government plans big push on generic drugs
06 February 2009
Glenmark receives approval from the US FDA for lithium carbonate capsules
05 February 2009
Schering-Plough’s quarterly results surpass expectations
04 February 2009
Study suggests insulin may be treatment for Alzeheimer's
03 February 2009
Troubled MDS may sell of divisions
03 February 2009
Pfizer discontinues global phase III trial of Axitinib for futility in advanced pancreatic cancer
31 January 2009
India, Brazil denounce seizure of medicines by Dutch authorities
31 January 2009
Amylin shares up as Icahn consolidates stake
31 January 2009
Roche lowers Genentech bid to $42 billion
30 January 2009
WHO shelves redefinintion amidst protest from Indian drug makers
27 January 2009
Pfizer-Wyeth create $68-billion blockbuster deal
27 January 2009
Glaxo buys UCB patents
24 January 2009
Stem cell study for spinal injury gets FDA nod
24 January 2009
Pfizer in talks to acquire Wyeth for $60 billion
23 January 2009
FDA woes hit Ranbaxy in Q4
23 January 2009
Unigene reports positive results on a novel peptide for reducing food consumption
21 January 2009
Ranbaxy affiliate Zenotech objects to open offer pricing
19 January 2009
India plans to move WTO as EU confiscates drugs in transit
16 January 2009
Eli Lilly to pay $1.42 billion to settle misdemeanor case regarding blockbuster drug Zyprexa
15 January 2009
Exact Sciences rebuffs Sequenom's $41 million buyout offer
13 January 2009
Abbott Laboratories acquires Advanced Medical Optics in $2.8 billion cash-and-debt deal
12 January 2009
American pharma major Wyeth looking to acquire Dutch vaccine maker Crucell
08 January 2009
Taro asks Sun to raise bid; proposes shareholder referendum
06 January 2009
Endo to acquire biopharma firm Indevus for $370 million
06 January 2009
Sun offers to buy Taro shares at a premium
05 January 2009
Daiichi Sankyo announces valuation loss for Ranbaxy acquisition of 359 billion yen
05 January 2009
Centre acquires controlling stake in 2 drug firms
02 January 2009
Pharma sales beat inflation
02 January 2009
American states receive million-dollar settlements from drugmaker Cephalon
31 December 2008
Amrutanjan to get makeover
26 December 2008
Piramal buys US-based Minrad to strengthen its position in anesthetics
24 December 2008
FDA warns consumers about tainted weight-loss products
23 December 2008
GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan
22 December 2008
Aurobindo Pharma gets USFDA nod for anti-HIV drug
22 December 2008
Malvinder gets additional charge of chairman in reconstituted Ranbaxy board
20 December 2008
Wyeth acquires British biotech firm
19 December 2008
Infosys wins multi-million dollar AstraZeneca deal
15 December 2008
Pharmaceutical companies asked to pass excise benefits to consumers
15 December 2008
Bristol-Myers Squibb, Exelixis to collaborate on two novel cancer molecules
12 December 2008
Eli Lilly reports new product development on track
12 December 2008
Merck launches division for follow-on biotech drugs
11 December 2008
Pharma sector attracts Atlas Cycles and Shanku Group
06 December 2008
Research proves branded drugs not superior to generics
05 December 2008
Wockhardt gets US FDA approval for paediatrics drug
04 December 2008
Ranbaxy in pact to market BioPro's brain tumour drug in India
03 December 2008
Eli Lilly sues Lupin, Aurobindo for patent infringement
03 December 2008
J&J buys breast implant maker Mentor Corp for $1.07 billion
01 December 2008
Plethico to take 20 per cent stake in CIS drug maker
29 November 2008
Drugmaker Eli Lilly withdraws drug application to treat chronic pain
29 November 2008
Drug firms misusing patents to block cheaper generics: EU
28 November 2008
Sun Pharma's US arm acquires Chattem
27 November 2008
AstraZeneca, Abraxis rethink cancer drug deal
26 November 2008
Johnson & Johnson acquires Omrix Biopharmaceuticas for $465 million
25 November 2008
King Pharma to acquire Alpharma for around $1.6 billion
25 November 2008
Glenmark gets US FDA approval for marketing Ranitidine
21 November 2008
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
AstraZeneca agrees to cut drug prices in UK, stock plummets
20 November 2008
Glenmark launches `Azathioprine' tablets in US
20 November 2008
Teva in bid to make generic version of Gilead's AIDS drug Truvada
15 November 2008
Wockhardt gets USFDA approval for insomnia drug sale
14 November 2008
US FDA observations not to affect drug sales: Lupin
14 November 2008
Zydus Cadila acquires Etna Biotech of Italy
11 November 2008
Glenmark starts selling pain killer drugs in US
10 November 2008
Sun Pharma extends offer for Taro till 19 December
10 November 2008
Amgen Positioned to Deliver Attractive Growth Over Next Five Years
08 November 2008
Daiichi Sankyo completes Ranbaxy acquisition
07 November 2008
Pfizer ends testing obesity drug on account of risk of US non-approval
06 November 2008
US Supreme Court split in Wyeth v/s Levine
05 November 2008
Genentech Submits application to US FDA for avastin for brain cancer treatment
04 November 2008
Sanofi's anti-obesity drug Acomplia pulled out of EU
25 October 2008
Exelixis says GSK drug research deal to end
24 October 2008
Eli Lily's suspension of arthritis drug development expected to hit Glenmark's pipeline
24 October 2008
Roche confirms plans to acquire remaining 44 per cent in Genentech
21 October 2008
Daiichi acquires 52.5 per cent in Ranbaxy
20 October 2008
Cadila gets USFDA approval antyi-depressant Risperidone
20 October 2008
Pfizer reaches $894 million settlement to resolve Bextra litigation
18 October 2008
Ranbaxy-Daiichi deal hits a regulatory bump
17 October 2008
Wockhardt gets US FDA nod to market Ceftazidime injections
16 October 2008
New anti-piracy law to be enacted in the US
15 October 2008
Abbott says its bioabsorbable drug-eluting stent could become next major breakthrough in interventional treatment
14 October 2008
Zydus Cadila receives WHO prequalification accreditation for Rabies vaccine
14 October 2008
Ipca Labs, US-based Heritage to market cardiovascular tablet, Propranolol in the US
13 October 2008
Ranbaxy-GSK submits IND application for respiratory inflammation candidate
13 October 2008
Chennai's Malladi Drugs to set up global hub in Malaysia
08 October 2008
Three scientists share Nobel prize for medicine
06 October 2008
Eli Lilly to acquire ImClone for $6.5 billion
06 October 2008
Jubilant in R&D, clinical trial joint venture with Eli Lilly
04 October 2008
Delayed approval of Ranbaxy deal brings $445 million windfall for Daiichi
04 October 2008
Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone
04 October 2008
Ely Lilly, Deciphera tie up for cancer drug research
03 October 2008
Advanced Life Sciences, Wyeth in Asian marketing pact for new drug
03 October 2008
US FDA probing deaths in German study involving J&J's anti-anemia drugs
03 October 2008
Emami woos Zandu shareholders by increasing offer price to Rs16,500
03 October 2008
Tata's Advinus Therapeutics, J&J arm in drug development pact
01 October 2008
Pharmaceutical offshoring to grow to Rs2,500 crore by 2012
29 September 2008
Orchid in pact with Merck & Co to develop novel anti-infective drugs
29 September 2008
Alpharma rejects King Pharmaceuticals’ $1.55 billion offer as inadequate
27 September 2008
Glenmark gets ANDA approval from US FDA for generic betamethasone corticosteroid
25 September 2008
Bristol-Myers Squibb raises bid for ImClone to $4.7 billion
23 September 2008
French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion
23 September 2008
Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA
18 September 2008
Lupin acquires majority stake in South Africa's Pharma Dynamics
18 September 2008
US FDA bans import of over 30 Ranbaxy generic drugs
17 September 2008
Bayer acquires German biotech drug developer Direvo Biotech AG
16 September 2008
CSIR launches open source drug discovery
16 September 2008
Emami doubles offer price to Rs15,000 per Zandu share
15 September 2008
ImClone rejects Bristol-Myers Squibb's $4.3 billion bid; cites $6.1 billion fresh offer
10 September 2008
Essar Gujarat in petrochem technology licencing deal with CB&I
09 September 2008
Biocon says its oral insulin is good for Type 2 diabetes
08 September 2008
US FDA to list names of drugs under investigation
06 September 2008
Sun extends offer for Taro by a month as Israeli SC stays acquisition
04 September 2008
Maoists shut Dabur’s Nepal factory
04 September 2008
Japanese drug maker Shionogi to acquire American rival for $1.1 billion
02 September 2008
Fish oil better than AstraZeneca's Crestor says new heart-failure study
01 September 2008
Sun Pharma wins Taro takeover case in Israel
27 August 2008
Cabinet likely to clear Daiichi-Ranbaxy deal next month
26 August 2008
Lupin acquires stake in Australian pharma firm Generic Health
21 August 2008
Lupin in marketing alliance with Forest for asthma product
19 August 2008
Management expansion at McCann Healthcare Worldwide
19 August 2008
Methadone a double-edged painkiller
18 August 2008
Sun Pharma gets US regulator's approval for Taro open offer
14 August 2008
Orchid Pharma to make Merck's anti-coagulant drug
14 August 2008
Genentech rejects Roche’s $43.7-billion takeover offer as too low
13 August 2008
Australian pharma firm CSL buys US rival Talecris for $3.1 billion
13 August 2008
Dr Reddy's, Teva settle `carvedilol' patent dispute: report
12 August 2008
Panacea Biotec secures Rs143 crore UNICEF order for `EasyFive' vaccine
12 August 2008
Pfizer to settle Lipitor case with Canada's Apotex
11 August 2008
Finance ministry clears Daiichi-Ranbaxy deal among 24 FDI proposals
06 August 2008
Daiichi to launch open offer for Ranbaxy on 16 August
05 August 2008
Carl Icahn finds Bristol-Myers' offer for ImClone Systems low
04 August 2008
Orchid receives EU approvals for anti-bacterial injections Piperacillin, Tazobactam
04 August 2008
Bristol-Myers Squibb completes sell-off of ConvaTec to PE firms
04 August 2008
Ranbaxy applies for US FDA approval for Mohali plant; says WHO approves new ARV drug
02 August 2008
US FDA rejects Schering-Plough's post-surgery drug Sugammadex
01 August 2008
Bristol-Myers Squibb to acquire ImClone Systems for $4.5-billion
31 July 2008
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
Sun set for a long battle for Taro
30 July 2008
Lupin enter Europe with acquisition of German pharma marketing agency Hormosan
30 July 2008
Ranbaxy banks on Pfizer settlement to revive falling fortunes
29 July 2008
After amlodipine in Japan, Ranbaxy launches omerprazole
28 July 2008
Agitators burn shed at Dow Chemical's construction site near Pune
26 July 2008
Roche bids for Genentech on Monday, acquires Mirus on Tuesday and Arius on Wednesday
25 July 2008
GlaxoSmithKline teams up with South Africa's Aspen to market branded generics
23 July 2008
Piramal Healthcare and Pierre Fabre launch French dermo cosmetic range in India
23 July 2008
US House representatives probe FDA approval of Ranbaxy drugs
23 July 2008
UK Crown court rejects charges against Ranbaxy
23 July 2008
Dr Reddy’s to buy back Perlecan Pharma stake from ICICI Ventures and Citigroup
22 July 2008
Bilcare Ltd, MeadWestVaco jointly acquire US pharmaceuticals packaging firm International Labs
21 July 2008
Sanofi-aventis to acquire Symbion Holdings for $544 million
21 July 2008
Roche makes a $43.7-billion bid for Genentech
21 July 2008
Clinton initiates cheap malaria drugs programme
19 July 2008
Biotechnology companies Genzyme and PTC Therapeutics ink $100 million deal
19 July 2008
No1 generic drugs maker Teva acquires rival Barr Pharma for $7.46 billion
18 July 2008
MNC rival trying to scuttle Daiichi deal: Ranbaxy
18 July 2008
Pakistan government blocks proposal to import Indian drugs
17 July 2008
FDA under probe as Ranbaxy says Daiichi deal is sealed
17 July 2008
Sun Pharma extends Taro tender offer
16 July 2008
Mark Mobius objects to Sun's acquisition of Taro
16 July 2008
Ranbaxy denies allegation of substandard drug sale; gets nod for stake sale
15 July 2008
Amgen to pay J&J's Ortho Biotech $200 million to settle suit
15 July 2008
Reports of coming under US FDA scanner hammer Ranbaxy stock
14 July 2008
India's first patent facilitation centre opens at Hyderabad
12 July 2008
Taro advises shareholders against Sun's open offer
11 July 2008
Novartis announces strategic partnership with Lonza to boost biologics pipeline
11 July 2008
Novartis to buy Swiss biotech company Speedel for $880 million
11 July 2008
Dr. Reddy's in global Ibuprofen marketing pact with Albemarle
09 July 2008
American drugmaker Eli Lilly buys biotech company SGX Pharma for $64 million
09 July 2008
Ahmedabad-based Veeda Oncology acquires International Oncology Network Clinical Research
08 July 2008
Fresenius to acquire APP Pharmaceuticals in $3.7-billion deal
07 July 2008
Ashok Kumar takes over as Secretary in the Department of Pharmaceuticals
07 July 2008
Panacea Biotec takes 75 per cent in Umkal to enter healthcare sector
05 July 2008
Cadila Healthcare to demerge consumer products division into Carnation, merge Zydus Hospitals with itself
05 July 2008
UK's Shire acquires maker of Firazyr, Jerini AG
04 July 2008
US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel
03 July 2008
Piramal Healthcare acquires PlasmaSelect's polygeline product Haemaccel
03 July 2008
Glenmark acquires 7 pharmaceutical brands in Poland
02 July 2008
Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration
28 June 2008
FDA bars use of Merck's cancer vaccine by women over 27
26 June 2008
Sun goes ahead with Taro acquisition; files suit in US court
26 June 2008
Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir
26 June 2008
US FDA delays approval on new drug by Eli Lilly and Daiichi Sankyo
25 June 2008
Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid
23 June 2008
Johnson & Johnson Nordic AB acquires Åmic
23 June 2008
Taro sues Sun Pharma again; alleges plan to block sale of Irish arm
20 June 2008
Glenmark gets USFDA approval for anti-hypertensive, Trandolapril
20 June 2008
Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva
19 June 2008
CNBC-TV18 shares with domain-b its exclusive interview with Malvinder Singh
18 June 2008
Pfizer and Ranbaxy settle global Lipitor patent litigation
18 June 2008
Cadila realigns consumer products division
18 June 2008
Boehringer Ingelheim to acquire Actimis Pharmaceuticals
18 June 2008
Daiichi to make open offer for Ranbaxy on August 8
16 June 2008
Bayer to make medicines from tobacco
16 June 2008
Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile
16 June 2008
Report on Pfizer move buoys Ranbaxy stock to a 3-year high
13 June 2008
Biotechnology giant Invitrogen plans to acquire peer Applied Biosystems for $6.7 billion
12 June 2008
Behind the Ranbaxy sale
12 June 2008
Glaxo to cut 350 R&D jobs in drug research revamp
11 June 2008
This is the start of a much larger game
11 June 2008
Ranbaxy struck deal at appropriate time: PwC
11 June 2008
Japan's Daiichi Sankyo to acquire majority stake in Ranbaxy
11 June 2008
Natco Pharma grants global marketing for its generic Copaxone to Mylan
10 June 2008
Taro selling Irish assets to thwart merger: Sun Pharma
06 June 2008
Biocon launches India's first pre-filled syringes
04 June 2008
Novartis buys US drug firm Protez for around $400 million
04 June 2008
Mylan Inc. acquires Merck KGaA's central eastern European generics businesses
02 June 2008
CuraGen presents encouraging results from ongoing Phase I / II study of CR011-vcMMAE in metastatic melanoma
02 June 2008
Emami buys 27.5 per cent in Zandu; to make open offer
31 May 2008
Bristol-Myers Squibb to buy anti-cancer drug maker Kosan Biosciences for $190 million
30 May 2008
Glenmark gets nod for marketing two drugs in US
30 May 2008
Zydus Cadila acquires Spanish drug firm Laboratories Combix
30 May 2008
Sun Pharma warns of legal action against Taro for stalling merger
29 May 2008
Israel's Taro to terminate merger with Sun Pharmaceutical
28 May 2008
Pharma firms threaten to stop production
28 May 2008
Alnylam in $1 billion RNAi drug research deal with Japan's Takeda
28 May 2008
Ranbaxy gets partial relief in `atorvastatin' case in Australia
28 May 2008
GVK BIO enters into drug discovery pact with Wyeth Pharmaceuticals
26 May 2008
Novo Nordisk seeks approval of new Type 2 diabetes drug in US, Europe
24 May 2008
Suven Life gets product patents in South Africa, China
20 May 2008
Zydus Cadila to market four products in the US after USFDA approval
16 May 2008
GlaxoSmithKline, Daiichi in hypertension drug deal in India
14 May 2008
Intercell to acquire Iomai Corporation for $189 million
13 May 2008
Ranbaxy to develop new drugs for Merck & Co
10 May 2008
Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada
09 May 2008
Jubilant Organosys acquires Speciality Molecules for about Rs20 crore
08 May 2008
Enzon Pharma to spin off biotechnology business
08 May 2008
Novo Nordisk researchers nominated for Europe’s top innovation prize for new version of insulin
06 May 2008
GSK Pharma signs licensing agreement with Astellas of Japan
05 May 2008
Indian vultures face extinction due to diclofenac poisoning
05 May 2008
Divested from Pfizer, Esperion Therapeutics completes $22.75-million series A financing
03 May 2008
Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion
03 May 2008
Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants
03 May 2008
Teams unravel heparin death mystery
02 May 2008
Dr Reddy's acquires BASF's contract manufacturing business in US
30 April 2008
Novartis Research announces breakthrough in restoring light sensitivity in damaged retinas
29 April 2008
US FDA turns down Merck's ER niacin / laropiprant
29 April 2008
Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea
28 April 2008
Brazil declares anti-AIDS drug to be of public interest; India's pharma industry may benefit
28 April 2008
Pfizer forms diabetes, obesity research consortium with universities
26 April 2008
Government brings 1,421 drugs under Price Control Order
25 April 2008
GlaxoSmithKline acquires Sirtris Pharmaceuticals
24 April 2008
Delhi HC upholds ruling in Cipla-Roche cancer drug row
23 April 2008
Ranbaxy forces Orchid into an alliance
22 April 2008
Dabur Pharma to sell majority stake to Singapore-based Fresenius Kabi Pte Ltd
19 April 2008
Nicholas Piramal buys two Khandelwal Laboratories brands for Rs116 crore
16 April 2008
Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US
15 April 2008
Why Ranbaxy fancies Orchid
14 April 2008
Ranbaxy group closer to 15 per cent stake in Orchid
14 April 2008
Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals
11 April 2008
Japan's Takeda to acquire Millennium Pharma for $8.8 billion
10 April 2008
Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500
10 April 2008
Orchid Chemicals announces Japanese subsidiary
10 April 2008
Orchid Chemicals stock surges as Ranbaxy group hikes stake
08 April 2008
Ranbaxy receives Japanese authorisation for product development outside Japan
08 April 2008
Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy
03 April 2008
Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis
03 April 2008
Teva to acquire Bentley Pharmaceuticals
01 April 2008
Dr Reddy's to buy two Dowpharma Small Molecules units in the UK
01 April 2008
Indian Pharma Industry should make 40 per cent of the world's generic drugs: APJ Abdul Kalam
31 March 2008
Aurobindo acquires Italian generic pharma firm TAD
24 March 2008
Wockhardt says derivative losses not to affect Q1 performance
24 March 2008
Cipla to continue selling its version of Roche's lung cancer treatment drug
20 March 2008
Japan's biggest drug maker to expand in the US
20 March 2008
Sun Pharma gets US FDA approval to market generic Cerebyx
20 March 2008
Ranbaxy to introduce dental drug Inersan in India, Nepal
18 March 2008
USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets
17 March 2008
Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline
17 March 2008
SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad
12 March 2008
Suven Life signs another drug research pact with Eli Lilly
12 March 2008
Dr Reddy's Laboratories and 7TM Pharma sign drug research pact
10 March 2008
USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar
07 March 2008
Pfizer to acquire Serenex, extend oncology pipeline
05 March 2008
Drug Controller approves Venus Remedies' latest antibiotic drug
04 March 2008
Drugs to become cheaper: Ram Vilas Paswan
01 March 2008
Dabur launches injection for cancer treatment in US
29 February 2008
Baxter withdraws heparin blood thinners made from Chinese supplies
29 February 2008
Matrix Labs may divest Docpharma
28 February 2008
Shasun Chemicals technology licenses API technology to Merck
27 February 2008
New Novartis Research Institute first to focus on innovative vaccines for the developing world
23 February 2008
Nicholas Piramal Research in India's first public-private drug research project
22 February 2008
Sun Pharmaceutical buys Taro Pharma shares from Brandes
20 February 2008
Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd
19 February 2008
AstraZeneca forms clinical research venture with private equity firms
18 February 2008
Zydus Cadila launches new drug for cancer therapy
15 February 2008
Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly
15 February 2008
Patent expiries destabilise global pharmaceutical majors, says Datamonitor research
14 February 2008
Wockhardt's Azithromycin to battle Pfizer's Zithromax in the US market
13 February 2008
Bayer HealthCare affiliate MEDRAD to acquire devises maker Possis Medical
12 February 2008
Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia
08 February 2008
Alpharma divests API business to 3i for $395 million
07 February 2008
Nicholas Piramal launches hypertension product
07 February 2008
USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US
07 February 2008
Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat
06 February 2008
US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales
06 February 2008
DiaGenic announces preliminary results from Indian breast cancer study
05 February 2008
Amgen and Takeda announce exclusive collaboration in Japan on up to 13 Amgen clinical candidates
04 February 2008
US FDA grants tentative approval to Teva's generic Flomax capsules
01 February 2008
Sun Pharma launches generic version of Wyeth's Protonix
30 January 2008
Shasun Chemicals to set up new facilities in N. America
28 January 2008
US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant
28 January 2008
Matrix Laboratories hikes stake in China's Mchem to 97 per cent
25 January 2008
Novo Nordisk divests three metabolic-disorder treatment programmes to TransTech Pharma
25 January 2008
Anti-smoking vaccines set to help millions; to boost prescription market
25 January 2008
Zydus Cadila to collaborate with US-based Prolong Pharmaceuticals for drug discovery
24 January 2008
Roche to acquire Ventana for $89.50 per share
23 January 2008
Teva to acquire CoGenesys
23 January 2008
Nicholas Piramal buys Healthline's pharmaceuticals business
23 January 2008
Suven Life Sciences receives second US patent
23 January 2008
Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline
21 January 2008
Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis
21 January 2008
Wockhardt to demerge R&D business
18 January 2008
Pfizer-funded study reports reduction in heart attacks by adding Lipitor early to blood pressure treatment
18 January 2008
India asks Indonesia to remove non-tariff barriers on Indian pharma products
18 January 2008
WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug
14 January 2008
Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active'
11 January 2008
US wants to open FDA office in India
11 January 2008
Strides Arcolab discontinues manufacturing operations in New Jersey
09 January 2008
Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen
08 January 2008
Marksans Pharma acquires UK’s Hale Group Ltd, owner of Bell, Sons & Co
07 January 2008
Panacea Biotec pre-qualified by WHO to supply children's immunisation drug
05 January 2008
National Pharmaceutical Pricing Authority seeks cost data from pharmaceutical industry
04 January 2008
Cephalon seeks second use for chemo drug
03 January 2008
Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US
02 January 2008
Suven Life Sciences receives first product patent in the US
27 December 2007
Aurobindo Pharma gets US approval to sell generic Omnicef
19 December 2007
Nicholas Piramal in JV with Japan's Arkray to market blood glucose monitoring products
19 December 2007
Health minister to release Indian Pharmacopoeia 2007
17 December 2007
Novartis plans to cut 22,00 jobs worldwide
13 December 2007
Drug prices fixed under DPCO 1995 have to be compulsorily implemented: Government
11 December 2007
Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent
11 December 2007
Eli Lilly predicts higher 2008 profit; to launch new products by 2011
07 December 2007
Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion
07 December 2007
US FDA panel rejects the use of Genentech’s Avastin for breast cancer
07 December 2007
Sun Pharma announces settlement of litigation over generic Exelon
06 December 2007
Matrix Labs gets US FDA nod for HIV drug
05 December 2007
Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks
05 December 2007
French drug giant Sanofi-Aventis opens R&D centre in Goa
05 December 2007
Pfizer to outsource 30 per cent of manufacturing to Asia, cut 10,000 jobs
04 December 2007
Bristol-Myers Squibb likely to cut 4,300 jobs
01 December 2007
Astellas acquiring cancer biotech firm Agensys
27 November 2007
Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products
24 November 2007
Nicholas Piramal in R&D collaboration with Merck & Co
19 November 2007
Pfizer to acquire Coley Pharmaceutical for $164 million
19 November 2007
US FDA approval Orchid's ANDA for Cefpodoxime Proxetil
17 November 2007
Dr Reddy's gets US FDA nod for marketing Ciprofloxacin
17 November 2007
Glenmark Pharma to spin off generics unit, list new unit next year
17 November 2007
Merck agrees to settle Vioxx claims for $4.85 billion
15 November 2007
GSK to launch cancer drug Tykerb in India
10 November 2007
Contract research firm Manipal AcuNova acquires Germany''s ECRON
05 November 2007
Pfizer to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032
01 November 2007
Biocon plans Rs 100 crore annual research spend
31 October 2007
Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany
30 October 2007
US state Utah seeks co-operation with India in life science research
30 October 2007
Glenmark signs up marketing deal with MyerZall Labs
27 October 2007
Sigma-Aldrich, Oxford BioMedica win key ruling in Open Biosystems patent infringement dispute
26 October 2007
Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa
25 October 2007
Ranbaxy launches Osonase nasal spray in India
25 October 2007
Suven Life Sciences, University of Minnesota to develop drugs jointly to treat HIV
25 October 2007
US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets
24 October 2007
Wockhardt acquires US pharma firm Morton Grove Pharmaceuticals
24 October 2007
Dabur enters supply and distribution agreement with Combino Pharm
24 October 2007
Researchers see role for `septins'' in treatment of Alzheimer''s, Parkinson''s
20 October 2007
Himalaya Drug Company to expand retail presence
19 October 2007
Medical Retail chain Medicine Shoppe to expand network outside Mumbai
19 October 2007
Ranbaxy follows Sun Pharma in demerging R&D business
19 October 2007
USV in marketing tie-up with Germany''s Sebapharma
19 October 2007
Drug Controller-General approves Biocon - Abraxis BioScience breast cancer drug Abraxane
19 October 2007
Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent
18 October 2007
Panjab University and Panacea Biotec to develop new chemical entities
10 October 2007
Government plans central authority for drug licensing
08 October 2007
Avesthagen-Cipla JV acquires Siegfried Biologics in Germany
05 October 2007
Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance
14 September 2007
Toray develops Hepatitis C vaccine
28 August 2007
Matrix to acquire residual holding in China''s Mchem group
25 August 2007
No data on of siphoning of funds by pharmaceutical companies: Minister
24 August 2007
Roche secures US court injunction for its Ventana bid
23 August 2007
Boston Scientific to explore divestment of surgical products unit
18 August 2007
Ranbaxy could gain as Pfizer loses initial bid for Lipitor patent extension
17 August 2007
Ajanta Pharma out licences formulation technology to Taiwan''s Orient Europharma
16 August 2007
Ipca-Ranbaxy alliance to market Metformin HCL tablets in US
14 August 2007
Lupin to invest Rs200 crore in new plant, capacity addition
10 August 2007
Unigene Laboratories acquires exclusive licence for therapies from University of London
10 August 2007
Biocon in pact with Abraxis to market breast cancer drug Abraxane in India
09 August 2007
Switzerland not to take Novartis case before WTO
08 August 2007
Patent tussle fallout: MNCs may turn cautious on India
07 August 2007
Bayer HealthCare and Nektar Therapeutics to develop innovative therapy for pneumonia
06 August 2007
Strides Arcolab completes acquisition of Diaspa''s fermentation facility in Italy
06 August 2007
Chennai court rejects Novartis patent challenge
06 August 2007
KKR Boots' debt may devolve on underwriters
04 August 2007
Dr Reddy's and Rheoscience commence Phase III diabetes drug trials
02 August 2007
Genstar makes another grab for PRA
31 July 2007
Merck buys cardiac biotech start-up NovaCardia
31 July 2007
Indonesia bans cosmetics, medicine and food from China
30 July 2007
Biocon enters into JV with Neopharma of UAE
30 July 2007
Ranbaxy to sell authorised generics product Isoptin SR in US
30 July 2007
Genstar to acquire contract drug manufacturer PRA for second time
28 July 2007
SNC-Lavalin acquires pharma engineering firm Pipecon
27 July 2007
Merck to acquire NovaCardia for $350 million
27 July 2007
Aventis group firm acquires diabetes drug technology from Themis
26 July 2007
Ranbaxy, GSK to settle valacyclovir patent case in US
26 July 2007
Elder Pharma to acquire 20 per cent stake in UK's Neutra Health
26 July 2007
GlaxoSmithKline pharmaceuticals divests fine
26 July 2007
Neutra Health acquisition to facilitate entry into regulated markets: Elder Pharma
26 July 2007
Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh
26 July 2007
Teleflex avquires medical products maker Arrow for $2 billion
25 July 2007
Nicholas Piramal''s new drug IND-P276 approved by US FDA
25 July 2007
Swedish pharma firm Meda to acquire Medpointe
23 July 2007
China asks tainted food and drug firms to shut down
23 July 2007
Purdue Pharma fined $634 million for OxyContin deaths; executives punished
22 July 2007
Court revives shareholder lawsuits over Vioxx against Merck
20 July 2007
Glenmark acquires rights to two therapeutic antibodies from Chromos
19 July 2007
Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug
19 July 2007
Abraxis BioScience to license biosynthetic cancer drug from Biocon
19 July 2007
Orchid Chem to launch three new products in the US
18 July 2007
World Bank blacklist two Indian pharma companies for ''collusive'' practices
17 July 2007
Rebuffed by Ventana, Roche may increase its $3-billion bid
13 July 2007
Dishman Pharma to acquire Solvay's Dutch fine chemicals unit
09 July 2007
Novartis AG receives first worldwide approval in US for Alzheimer''s patch
09 July 2007
Roche goes to court over Ventana''s poison-pill defence
05 July 2007
Roche makes hostile offer for Ventana
27 June 2007
Roche buys Toyama''s arthritis drug for $370 million
26 June 2007
Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin
25 June 2007
Zydus Cadila acquires Brazilian company Nikkho
25 June 2007
US panel blocks Sanofi''s weight-loss drug
16 June 2007
China slaps anti-dumping duty on antibiotic from India
16 June 2007
Dr Reddy's commences operations in Nigeria
16 June 2007
Aurobindo Pharma rules out stake sale
13 June 2007
Rising disease may take India to top 10 pharma markets by 2020
13 June 2007
Strides Arcolab acquires Grandix for Rs100 cr
12 June 2007
Nicholas Piramal in tie-up for cancer, diabetes research
11 June 2007
Nigeria sues Pfizer for illegal drug trials, claims $7 billion in damages
05 June 2007
Strides Arcolab to buy Italian Diaspa''s drug unit
29 May 2007
Ranbaxy buys 13 dermatology brands from Bristol-Myers
28 May 2007
Alembic enters into licensing pact with Belgian co
24 May 2007
Indian pharma to grow big in few years
24 May 2007
NPPA strikes drug firms for raising MRP
24 May 2007
Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone
21 May 2007
Sun Pharmaceutical to acquire Taro Pharma for $454 million
21 May 2007
Dr Reddy's is setting up two SEZs
19 May 2007
Glenmark receives US FDA approval for cardiac and NSAIDs generics
16 May 2007
Mylan Laboratories to acquire Merck generics unit for $6.6 billion
14 May 2007
FDA fines US drug firm $634m over painkiller misleads
11 May 2007
FDA panel seeks curbs on Amgen, J&J anaemia drugs
11 May 2007
Dabur Pharma sets up US subsidiary
09 May 2007
Wockhardt acquires France`s Negma Labs for Rs1,090 crore
03 May 2007
Internal accruals to fund Negma acquisition: Khorakiwala
03 May 2007
AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion
28 April 2007
Jubilant Organosys acquires Hollister-Stier of US for $122.5 million
26 April 2007
KKR-Pessina combine to buy Alliance Boots for $22.2 billion
25 April 2007
US FDA approves Ranbaxy''s pravastatin sodium tablets
25 April 2007
Wockhardt to launch Italy''s B-Lift range of dermatology products in India
23 April 2007
Zydus Cadila acquires Nippon Universal of Japan 19 April 2007
19 April 2007
Wockhardt to introduce treatment for dermatological scars
17 April 2007
Nestle to acquire Gerber for $5.5 billion; eyes US expansion
12 April 2007
Lupin gets USFDA approval for paediatric Suprax oral suspension
12 April 2007
Bidding battle expected for Boots
10 April 2007
Government warns Novartis of compulsory licensing
10 April 2007
Orchid enters Canadian market with two generic formulations
10 April 2007
Lupin sells part rights of 'perindopril' to French firm for Rs115 crore
07 April 2007
Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science
07 April 2007
India court reserves order in Novartis patent case
05 April 2007
Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility
04 April 2007
Ranbaxy-GSK alliance to develop respiratory drug
02 April 2007
Eli Lilly sues Sun Pharma over patent for cancer drug
02 April 2007
Alliance Boots gets revised $20 billion offer from KKR, Pessina
31 March 2007
Novartis slumps after pulling Zelnorm
31 March 2007
Ranbaxy launches asthma drug 'Osovair' in India
30 March 2007
Strides Arcolab gets tentative US FDA nod for AIDS drug
29 March 2007
Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets
28 March 2007
Wockhardt receives US FDA approval for diuretic injection
28 March 2007
Government to enforce 5-per cent cut in prices of 75 drugs
27 March 2007
Glenmark acquires Czech firm Medicamanta
26 March 2007
Is Torrent a serious contender for Merck?
23 March 2007
Opportunities for India in generic drug space
21 March 2007
Ranbaxy withdraws bid for Merck's generic business
20 March 2007
Zydus Cadila acquires Liva Healthcare
17 March 2007
Ranbaxy enters second round of bidding for Merck unit: report
16 March 2007
Ranbaxy gets USFDA nod for zolpidem tablet production in US
16 March 2007
Strides Arcolab receives US FDA approvals for two new drugs
14 March 2007
Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb
14 March 2007
Akzo Nobel sells Organon BioSciences to Schering-Plough for €11 billion
13 March 2007
Ranbaxy Laboratories Bids for Merck''s Generic Unit
13 March 2007
Boots rejects KKR's £9.7 billion offer as being low
13 March 2007
Lupin gets marketing approval for cefpodoxime proxetil in France
13 March 2007
Merck suffers adverse Vioxx lawsuit in the US
13 March 2007
Boots to consider KKR's £9.7 billion offer
12 March 2007
Glenmark in funded research agreement with Swiss firm Dyax
12 March 2007
After acquiring Schering, Bayer to cut 6,100 jobs worldwide
03 March 2007
US firm acquires global rights for anti-cholestrol drug from Ranbaxy
01 March 2007
Ranbaxy plans ADS offering to finance Merck arm acquisition
21 February 2007
Biocon to invest Rs 1,000 crore in Vizag SEZ
17 February 2007
ADAG to rewrite drug distribution rules
10 February 2007
Ranbaxy enters biosimilar product space with Zenotech, targets EU markets
08 February 2007
Ranbaxy-Glaxo extend pact
07 February 2007
Pfizer loses battle for Chinese name for Viagra
06 February 2007
Dr Reddy's to join the race for Merck's generic business
05 February 2007
Glaxo moves court against Ranbaxy''s generic drug
03 February 2007
Wyeth sued over Zosyn patent
03 February 2007
Global collaboration to develop new anti-obesity compounds
02 February 2007
Pfizer wins Norvasc patent case against Synthon
02 February 2007
Novartis patent case a threat to developing nations: Medecins Sans Frontieres
30 January 2007
Ranbaxy launches two NDDS Urology products in India
30 January 2007
Sun Pharma to acquire companies in the US
24 January 2007
Pfizer to retrench 8,000
22 January 2007
US move to prevent restrictions on generic drugs
18 January 2007
Biocon grants marketing license for cancer drug in Pakistan
18 January 2007
Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit
12 January 2007
Organon Biosciences in biopharma development deal with China's Huya Bioscience
10 January 2007
Mylan completes stake acquisition in Matrix
10 January 2007
Ranbaxy to bid over $5 billion for Merck Generics
09 January 2007
Suven Life Sciences Secures Patent
09 January 2007
Only 12 per cent of drugs market to be under price control
08 January 2007
Biocon in joint venture with Abu Dhabi-based Neopharma
06 January 2007
Chemists body in TN plans distribution firm
05 January 2007
Dabur launches new delivery system for anti-cancer drug
04 January 2007
Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets
02 January 2007
Lupin awarded tentative US FDA approval for sertraline
02 January 2007
Aurobindo Pharma acquires Dutch company
30 December 2006
Ipca's 'Atenolol' bulk drug registered in China
29 December 2006
Wockhardt, Dr Reddy's launch generic Ondansetron in the US
27 December 2006
Biocon subsidiary Clinigene completes phase-IV study on new generation insulin
26 December 2006
Aurobindo receives approval for AIDS drug
22 December 2006
Iceland''s Actavis acquires manufacturing plant in Chennai
22 December 2006
Reliance Life Sciences to acquire UK's GeneMedix
22 December 2006
Why is RLS interested in GeneMedix?
22 December 2006
Ranbaxy wins Lipitor patent against Pfizer in Australia
21 December 2006
Eli Lilly accused of concealing health risks of Zyprexa
19 December 2006
Glaxo buys Genmab's leukemia drug for record $2.1 billion
19 December 2006
Ranbaxy, department of science and technology to jointly develop new drugs
18 December 2006
Ayurvedic mouthwash to relieve radiation pain in cancer patients
16 December 2006
Nestle acquires Novartis nutrition food unit for $2.5 billion
15 December 2006
Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets
15 December 2006
Glenmark to start clinical trials of painkiller in Europe
14 December 2006
J&J's acquisition of Pfizer Healthcare passes anti monopoly scrutiny
13 December 2006
Forest''s Lexapro tops anti-depresant drug trial
08 December 2006
Akorn-Strides JV takes product pipeline to 29 ANDAs
07 December 2006
Dabur Pharma gets US FDA approval for cancer drug
07 December 2006
Glenmark signs an additional deal for seven ANDAs with LVT
07 December 2006
Panacea signs joint venture pact with Cambridge Biostability of UK
06 December 2006
Pfizer aborts cholesterol drug tests
04 December 2006
Ranbaxy acquires South Africa's fifth largest generics company
01 December 2006
Dr Reddy's to raise Rs 1,027 crore through additional ADS issue
30 November 2006
Torrent in pact with DRL to market Listril and Listril Plus in Russia
29 November 2006
FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin'
25 November 2006
Nicholas Piramal signs collaboration pact with BioSyntech
17 November 2006
Glenmark develops API for Napo''s phase III diarrhoea drug trials by US
17 November 2006
Tata Group''s Advinus to develop metabolic drugs for Merck
16 November 2006
US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s
15 November 2006
Zydus Cadila files novel drug candidate for obesity disorders
14 November 2006
Abbott''s Kos acquisition driven by growth in cholesterol market
09 November 2006
Merieux Alliance acquires majority stake in Shantha Biotechnics
09 November 2006
Panacea Biotec's R&D centre gets government recognition
07 November 2006
Drug makers turn from blockbusters to ''niche-busters'' for future growth
03 November 2006
Government reduces dealer margins on 886 medicines
31 October 2006
Orchid to help Swedish drug major in drug research
30 October 2006
Nicholas Piramal signs R&D licensing agreements with UK''s Morvus Technology
27 October 2006
Ranbaxy to introduce Debiopharm's gastro drug in India
23 October 2006
New Drugs Act: What''s in store for Indian drug industry?
19 October 2006
Claris Life Sciences to expand capacity and product portfolio
13 October 2006
Granules India forms joint venture with Chinese company
12 October 2006
Step towards full backward integration with supply chain says Granules MD
12 October 2006
Torrent signs in-licensing deal to market Chinese cardiac blockbuster
11 October 2006
Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row
10 October 2006
US FDA approves Aurobindo Pharma''s Meloxicam for US sales
06 October 2006
IPCA phases out single ingredient malarial drug; launches India's first ACT
06 October 2006
Pfizer still biggest player in highly prized indication: Datamonitor
06 October 2006
Nicholas Piramal acquires Boots Piramal Healthcare
03 October 2006
Wockhardt acquires Pinewood for $150 million, fourth European acquisition
03 October 2006
Dr Reddy’s, ClinTec International announce co-development of anti-cancer compound
28 September 2006
Dr Reddy's opens manufacturing facility at Visakhapatnam
26 September 2006
Sterling Bio to acquire gelatin company in China
26 September 2006
JB Chemicals, Matrix Labs in licensing agreement with Gilead Sciences for HIV drug
22 September 2006
Ipca Laboratories in marketing alliance with Ranbaxy for US sales
21 September 2006
Germany''s Merck acquires Europe''s largest biotech company
21 September 2006
Orchid's formulation and API facilities approved by UK MHRA
21 September 2006
US FDA approves Ranbaxy's sale of furosemide in the US
21 September 2006
German Remedies launches third-generation inhaler for asthamatics
20 September 2006
Biocon launches cancer anti-body drug BioMab-EGFR
18 September 2006
Fifth volume of Ayurveda Pharmacopoeia released
18 September 2006
Dr Reddy's acquires Spain's Litaphar: CNBC
18 September 2006
Ranbaxy to market Ethypharm's cardiovascular drug in India
18 September 2006
Wockhardt to develop SEZ near Aurangabad for its global biopharma hub
18 September 2006
Is pharma retailing the next big opportunity?
13 September 2006
Wockhardt close to acquiring Pinewood: CNBC
13 September 2006
Ranbaxy receives US FDA nod to market loperamide hydrochloride and simethicone tablets
11 September 2006
Government to grant limited period protection for new drugs
05 September 2006
Biocon's Syngene International and Sweden's Innate Pharma to develop virulence blockers
04 September 2006
Strides Arcolab to acquire drug unit in Singapore
01 September 2006
Wockhardt's Cefotaxime injection receives US FDA approval
31 August 2006
India to host Asia biotech meet
30 August 2006
Ranbaxy wins two additional atorvastatin patents in Norway
30 August 2006
Aurobindo betalactum facility receives MCC South Africa's approval
28 August 2006
Mylan Labs to acquire Matrix Labs for $736 million
28 August 2006
Update: Generic API biz to strengthen post deal says Matrix Labs CEO
28 August 2006
Mid Pharma looks outside itself to drive revenue: Datamonitor
26 August 2006
TAKE Solutions wins Dabur Pharma order
24 August 2006
Dishman Pharmaceuticals acquires Carbogen AMC1S from Solutia
23 August 2006
GSK withdraws patent plea for AIDS drug Combivir
21 August 2006
Aurobindo gets marketing approval for mirtazapine tablets in UK
18 August 2006
Unbranded drugs may get cheaper by 50-60 per cent
18 August 2006
Expect Tazobactum approval by June 07: Orchid Chem
16 August 2006
Suven completes pre-clinical trials of new drug molecule
16 August 2006
Aurobindo gets second MHRA approval in UK for mirtazapine tablets
09 August 2006
Panacea Biotec granted patent for 'controlled release' nimesulide composition
07 August 2006
Ranbaxy receives tentative US FDA approval to market Risperidone oral solution
05 August 2006
Glenmark gets DCGI nod for Phase II trials of diarrhoea drug
03 August 2006
Mixed victory for Ranbaxy in patent row with Pfizer
03 August 2006
Orchid to acquire 100 per cent in US drug discovery unit Bexel
01 August 2006
Orchid Chemicals hosts presidential visit at its formulations complex
31 July 2006
Hope to maintain margins at 15 per cent: JB Chemicals
29 July 2006
US FDA approves drug to treat rare genetic disease
25 July 2006
Gates Foundation to fund collaborative research for HIV vaccine
20 July 2006
Lupin gets US FDA approval for Meloxicam
20 July 2006
Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain
18 July 2006
ReAble to acquire DJO for $1.6 billion
18 July 2006
Panacea opens new Baddi facility and office in Mumbai
17 July 2006
Glenmark, Merck''s Generics in derma products pact in the UK
17 July 2006
Panacea to market PT Bio's measles vaccine
12 July 2006
Aurobindo receives US FDA approval for 3-in-1 ARV combination
03 July 2006
Welspun acquires UK''s top towel brand, Christy
03 July 2006
New Genentech eye drug gets FDA approval
01 July 2006
Ranbaxy's 'Cefprozil' gets US FDA approval
01 July 2006
Bayer divests diagnostics to Siemens, eases impact of Schering acquisition
30 June 2006
Wockhardt acquires Dumex with Protinex, Farex brands from Royal Numico NV
30 June 2006
GE ties up with Manipal Hospital for clinical trials
29 June 2006
U K appeals court affirms HC ruling in Ranbaxy-Pfizer case
28 June 2006
J&J to acquire Pfizer Consumer Healthcare for $16.6 billion
26 June 2006
Wockhardt UK expanding Byetta manufacturing capacity
16 June 2006
Nicholas Piramal to acquire Pfizer''s UK Facility
15 June 2006
Merck & Co develops new diabetes drug
14 June 2006
Croatian drug firm Pliva opens research facility in India
14 June 2006
Wockhardt gets US FDA approval for anti-epilepsy drug
14 June 2006
Paul Royalty to finance drug development by Glenmark
05 June 2006
Wockhardt in-licenses dermatology drug from LSI of UK
05 June 2006
Wockhardt receives US FDA approval for clarithromycin tablets
01 June 2006
Zydus Cadila receives US FDA approval to market Warfarin in the US
01 June 2006
Lupin to acquire 51-per cent stake in Dafra
25 May 2006
Dishman to acquire Solutia's pharmaceutical services business
24 May 2006
Lupin gets US FDA approval for Cefdinir
24 May 2006
Dr Reddy's launches oral bronchodilator for asthma, COPD
16 May 2006
US FDA approves Wockhardt's Waluj plant
11 May 2006
Roche reports strong global sales for Tamiflu
27 April 2006
Biocon Biopharmaceuticals’ new biologics facility
17 April 2006
Dr Reddy's receives US FDA approval for fexofenadine hydrochloride
13 April 2006
Pharmacies gear-up to ride the retail boom
12 April 2006
Glenmark, is India''s first pharma company to implement ''structured product labeling''
31 March 2006
Pfizer India Q1 net jumps 84 per cent
29 March 2006
Ranbaxy to acquire Glaxo's generic business in Italy
28 March 2006
Ind Swift Laboratories API facility gets TGA certification
22 March 2006
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
Ranbaxy acquires patent & rights for auto-injector device
21 March 2006
Zydus Cadila to commence phase II clinical trials on ZYH1
20 March 2006
Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma
17 March 2006
Aurobindo receives first NDA approval for HIV-1 drug from US FDA
16 March 2006
Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs
16 March 2006
Ranbaxy Laboratories ties-up with Zenotech to market cancer injectibles
09 March 2006
Aurobindo Pharma receives final US FDA approval for Mirtazapine ODT 45mg
02 March 2006
Wockhardt receives US FDA approval for Ranitidine OTC version
27 February 2006
Setback for Ranbaxy; Finnish court reverses earlier verdict on Lipitor
22 February 2006
Merck wins second Vioxx lawsuit
18 February 2006
Ranbaxy raises $400 million from FCCB issue
16 February 2006
Glenmark Pharmaceuticals announces new drug discovery for obesity
13 February 2006
Glenmark Pharmaceuticals Clinical Research unit in India receives ANVISA approval
08 February 2006
Ranbaxy forms South African JV to sell AIDS drug
06 February 2006
Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm
03 February 2006
Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs
02 February 2006
Dr Reddy's Laboratories enters into agreement with Merck
01 February 2006
Natco Pharma acquires 75 per cent in US retail store
31 January 2006
Boston Scientific beats J&J to acquire Guidant for $27 billion
25 January 2006
Aurobindo receives UK MHRA approval
20 January 2006
Strides Arcolab signs partnership with The Clinton Foundation for HIV Drugs
13 January 2006
Ranbaxy in co-marketing agreement with Ferring of Switzerland
10 January 2006
Dishman Pharmaceuticals clarifies news item
06 January 2006
Shasun Chemicals signs LoI with to acquire plants, processes, patents of French firm
06 January 2006
JB Chemicals, Taro Pharmaceutical in product development agreement
05 January 2006
Glenmark Pharmaceuticals acquires Bouwer Bartlett, South Africa
26 December 2005
Wockhardt amongst first to receive US FDA approval for Zonisamide Capsules
26 December 2005
Roche grants Tamiflu licence to Hyderabad firm Hetero Drugs
24 December 2005
US FDA grants tentative approval to Aurobindo''s anti-AIDS drug for children
23 December 2005
Merck, ICMR to conduct joint trials on cervical cancer vaccine
22 December 2005
Ranbaxy, Cephalon to settle Provigil patent litigation
22 December 2005
JB Chemicals to set-up wholly owned subsidiary in Russia
21 December 2005
Dishman Pharmaceuticals acquires IO3S, Switzerland
20 December 2005
Natco Pharma finalises terms for supply of two onco formulations
20 December 2005
US FDA approves Lupin's cefprozil suspension, Orchid's tablets
20 December 2005
Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents
19 December 2005
TCS to provide end-to-end clinical trial data management solution for Novo Nordisk
19 December 2005
Zydus Cadila to set up JV with Bharat Serum; files second IND
16 December 2005
Aurobindo Pharma selected for IDMA''s patents appreciation award.
15 December 2005
Glenmark Pharmaceuticals, InvaGen Pharmaceuticals in marketing tie-up
15 December 2005
Final US FDA approval for Aurobindo''s Mirtazapine oral disintegrating tablets
14 December 2005
Aurobindo Pharma''s anti-AIDS drug selected by WHO
12 December 2005
Natco Pharma receives Patent Appreciation Award
12 December 2005
Transgene Biotek develops oral vaccines for diabetes and Hepatitis B
07 December 2005
Ranbaxy offers to help U S combat avian flu
02 December 2005
Orchid Chemicals hosts presidential visit at its formulations complex
02 December 2005
New Indo-UK JV company to recruit patients for drug trials
01 December 2005
Lupin receives US FDA approval for Cephalexin capsules
01 December 2005
Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets
29 November 2005
Ranbaxy honours scientists for outstanding research
28 November 2005
Government to set up separate pricing models for different drug categories
28 November 2005
Lupin receives IND approval from DCGI for Desoris LLL-3348
28 November 2005
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
US Court of Appeals upholds preliminary injunction against Ranbaxy
23 November 2005
AstraZeneca sues Ranbaxy on Nexium patent
22 November 2005
Zydus Cadila receives approval for Sertraline from AFSSAPS, France
22 November 2005
Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug
10 November 2005
Dr Reddy''s to acquire Roche business in Mexico
08 November 2005
Orchid Chemicals' fire victims were insured: K Raghavendra Rao
08 November 2005
Venkat Pharma secures $400,000-US order for dietary supplements
02 November 2005
AstraZeneca and Nicholas Piramal sign ''development and know-how'' agreement
27 October 2005
Nicholas Piramal acquires UK''s Avecia for £9.5 million
27 October 2005
CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling
15 October 2005
Glenmark Pharmaceuticals targets GPs
10 October 2005
Orchid, AstraZenwca, receive Frost and Sullivan pharma awards
03 October 2005
Zydus Cadila receives tentative US FDA approval for Ribavirin tablets
03 October 2005
Aurobindo receives approval for sertraline hydrochloride tablets
27 September 2005
Unichem Laboratories to step up R&D from Bangalore
23 September 2005
Matrix acquires 43 per cent stake in Swiss firm Explora Labs
21 September 2005
Pharma sector to top Rs.60,000 crore by ''08
21 September 2005
NPPA revises 16 bulk drug prices
20 September 2005
Government evaluating ''data exclusivity'' demand of pharma companies
17 September 2005
Eisai becomes first Japanese pharma firm to enter India
17 September 2005
Ranbaxy obtains US FDA approval for high BP drug
14 September 2005
Shanta Biotechnics launches 4-in-1 combination vaccine
20 August 2005
Eli Lilly launches anti-diabetes drug variant
11 August 2005
Sun Pharma to buy manufacturing site in Hungary
11 August 2005
Wockhardt becomes only pharmaceutical Superbrand in India
20 July 2005
Wockhardt joins $billion league
20 July 2005
Aurobindo Pharma plans to raise funds from global markets
06 July 2005
Ranbaxy, JB Chem to market Doktor Mom brand in Romania
06 July 2005
Maharashtra FDA questions claims of nutraceuticals
28 June 2005
Matrix Labs acquires Belgian drug firm Docpharma for $263 m
20 June 2005
German Remedies launches anti Leukaemia drug
09 June 2005
Nectar Lifesciences to come out with Rs100cr IPO
07 June 2005
Kopran to shift focus to global markets
06 June 2005
Zydus Cadila commences phase I clinical trials on ZYH1
03 June 2005
USFDA gives tentative nod for Ranbaxy drug
01 June 2005
Zydus in JV with Australia's Mayne to manufacture oncology products in India
19 May 2005
Diovan receives EU approval for the treatment of heart attack survivors
10 May 2005
HCL Tech and IIT Delhi to work on new drugs
04 May 2005
Shantha Biotech introduces "JENCEVAC" vaccine to combat fatal brain fever
18 April 2005
Quintiles expands India operations with new clinical data management services
12 April 2005
Johnson & Johnson launches the stent war
29 March 2005
Glenmark acquires another brand in Brazil
18 March 2005
Patent Bill to be introduced next week
17 March 2005
Orchid in deal with Stada for generic drug products
17 March 2005
Mexican mission woos Indian drug majors
16 March 2005
GSK India announces buyback
15 March 2005
On the clinical trial trail
11 March 2005
Zydus ties up Mallinckrodt to market generics in USA
10 March 2005
GlaxoSmithKline to locate first Indian vaccine plant at Nashik
23 February 2005
Global pharmaceutical firms plan investments in India
19 February 2005
Nicholas Piramal signs seven alliances
19 February 2005
GlaxoSmithKline Q4-05 up at 61.4%
17 February 2005
Wockhardt launches India''s first automatic insulin delivery device and recombinant insulin cartridge
17 February 2005
The rest didn''t do badly, either
16 February 2005
Dr Reddy''s cardio drug candidate undergoing clinical trials
09 February 2005
Zydus Cadila files its first IND application for new molecule
09 February 2005
InnoCentive signs MoU with IICT, Hyderabad
04 February 2005
Pharma, IT to benefit from patents: Evalueserve
04 February 2005
Zydus Cadila receives US FDA approvals for Clindamycin
01 February 2005
Ranbaxy makes three fresh ARV filings to WHO
25 January 2005
Shantha Bio launches DNA Erythropoietin
24 January 2005
Ranbaxy Top brass reshuffled
22 January 2005
Dr Mahendra Patel joins Zydus Pharmaceuticals
20 January 2005
Ranbaxy Q4 results disappoints
19 January 2005
Zydus Cadila to host second international symposium on genomics and proteomics
14 January 2005
Shantha Biotech Introduces Shanvac-B in BD UnijectT
10 January 2005
New Year rings in new patents regime for pharma cos
01 January 2005
Nicholas Piramal to take over UK''s Rhodia
18 December 2004
Zydus and Mayne (Australia) sign MoU for JV in India
13 December 2004
Bonanza ahead for generic drug majors
09 December 2004
Sun Pharma to issue $75 million FCCB
06 December 2004
Pankaj Patel declared 'best pharma man of the year' by FIIE
01 December 2004
Sun Pharma launches $225 million FCCB
19 November 2004
Paswan caps drug prices
18 November 2004
Ranbaxy withdraws its antiretroviral''s from WHO list
10 November 2004
Stronger performance from Shasun Chemicals and Drugs Limited
18 October 2004
CII pharma summit for ''India pharma Inc''
13 October 2004
Hanmer & Partners acquires Doc Asia
27 August 2004
Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France
18 August 2004
Fortis to invest over Rs1,100 crore in integrated healthcare delivery system
17 August 2004
Nicholas Piramal in research collaboration with National Institute of Immunology
12 August 2004
Dishman Pharma setting up new R&D facility
11 August 2004
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
11 August 2004
Professionals take over
06 August 2004
Sun Pharmaceuticals proposes share swap with Phlox Pharma
03 August 2004
Ranbaxy net down six per cent
02 August 2004
Orchid registers turnover of Rs173.86 crore for Q1 FY 2004-05
31 July 2004
Charak Pharma in joint venture with IL&FS Investmart
23 July 2004
Acer and TVS Electronics enable sales force automation for Dr Reddy's Laboratories
20 July 2004
India emerges as global hub for pharma outsourcing
12 July 2004
Jagsonpal spreads its wings
10 July 2004
Pen G industry demands a strong shot
01 July 2004
Natco Pharma unveils new drug
26 June 2004
Medicine Shoppe to double number of outlets this fiscal
25 June 2004
Biological E to launch hepatitis-B vaccine `Bevac` in three months
16 June 2004
Jagsonpal amongst India's top fifty pharma companies
16 June 2004
Cadila eyes overseas growth opportunities
09 June 2004
FIIs pull out of Dr Reddy''s Laboratories
31 May 2004
Interview with Sandoz GmbH CEO Christian Seiwald
31 May 2004
Krebs to diversify
31 May 2004
Orchid in tie up with Par Pharmaceuticals Inc. to market oral cephalosporin in the US
28 May 2004
Sun Pharma plants get US regulatory clearance
28 May 2004
Two Sun Pharma units gets USFDA approval
27 May 2004
Granules India gets USFDA nod
24 May 2004
Orchid's US discovery JV successful
22 May 2004
Ipca launches India's first novel injectible antibiotic combination
20 May 2004
Orchid files ANDA for Cefazolin finished dosage form
15 May 2004
Templeton Strategic acquires 2.9 per cent stake in Aurobindo Pharma
08 May 2004
Dr Reddy''s acquires US company Trigenesis
07 May 2004
Wockhardt acquires German firm Esparma
07 May 2004
Sanofi India's fortune looking up
05 May 2004

03 May 2004
Jagsonpal Pharma net rises 227 per cent
03 May 2004
Ranbaxy in pact for new drug discovery
30 April 2004
Novartis launches development centre in Mumbai
28 April 2004
Zydus Cadila reports highest ever sales, net profits up 87 per cent
27 April 2004
Global pharma eyes India as BPO hub
26 April 2004
Orchid's net profit rises 59 per cent on Rs 713 crore turnover during '03 -'04
26 April 2004
1:1 bonus from Sun Pharma
24 April 2004
Maxfair Drugs launches ayurvedic formulations in Kerala
24 April 2004
Orchid Pharma soon to file ANDA from its new plant
13 April 2004
Suven Life Sciences institutes scientific advisory board for CNS research
13 April 2004
Orchid Pharma soon to file ANDA from its new plant
02 April 2004
Zydus Cadila gears up for the US market
02 April 2004
Shreya launches new generation ''Viagra'' variant
01 April 2004
Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs
31 March 2004
Orchid granted Certificate of Suitability for Cefadroxil Monohydrate
30 March 2004
Proalgen Biotech to expand operations
29 March 2004
Dishman IPO price band finalised
25 March 2004
Nicholas Piramal expands its Clinical Research facility
24 March 2004
Orchid to raise USD 75 million through FCCBs
20 March 2004
GlaxoSmithKline, Burroughs Wellcome boards approve merger
18 March 2004
Zydus Cadila launches Nucoxia
17 March 2004
Sun Pharma increases holding in Caraco
16 March 2004
Matrix Labs gets US approval for second unit
13 March 2004
Ranbaxy crosses the billion dollar mark
11 March 2004
Morepen gets USFDA approval for API manufacturing
09 March 2004
US reinsurers wary of Indian pharma firms
09 March 2004
Product patents a major issue at Bio Asia
01 March 2004
Pfizer recalls liquid Gelusil
28 February 2004
One more CoS for Orchid Chemicals
19 February 2004
Pharmexcil to be headquartered in Hyderabad
10 February 2004
Sun Pharma to increase holdings in Caraco to 60 per cent
09 February 2004
Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.
07 February 2004
Nicholas Piramal Q3 growth up 76.1 per cent
07 February 2004
Sun Pharma logs healthy growth
03 February 2004
Ranbaxy enters the field of herbal medicine
22 January 2004
HAL and RCF divestment gains momentum
19 January 2004
Orchid posts good Q3 performance
16 January 2004
USFDA approval for Ranbaxy drug
10 January 2004
Nicholas Piramal, SPPL debt programmes reaffirmed A1+
06 January 2004
Vera Laboratories to come out with a preferential issue
02 January 2004
Orchid A